The eczema therapy guide maps
how it is treated. This page covers everything that doesn’t fit on it — the
detail, the confusion, the things people are told that aren’t true, and the questions
that are easier to type at 1am than to ask out loud.
133 answers across 18 areas ·
39 carry a verified source · nothing here is for sale
Is this even what I have?
Look-alikes, misdiagnosis, self-diagnosis limits, what confirmation actually involves, how a clinician tells it apart.
Infant eczema is itchy, comes and goes, and favours cheeks and outer limbs. Cradle cap is greasy and unbothersome; anything blistering or in crops needs seeing.
Read the full answerHide the full answer
Several rashes are common in the first year and they behave distinctly. Infant eczema is dry, itchy and recurrent, typically on the cheeks, forehead, scalp and the outer surfaces of the arms and legs, sparing the nappy area — a baby with eczema rubs, squirms and sleeps badly. Seborrhoeic dermatitis, or cradle cap, produces greasy yellow scale on the scalp and in the folds, appears early, does not itch, and resolves without much intervention. Nappy rash is confined to the covered area. Two need prompt attention rather than a cream: scabies, which produces intensely itchy bumps including on the palms and soles and affects other household members, and any crop of blisters, punched-out sores, or a rash with fever, which needs same-day assessment. Heat rash and viral rashes are common and self-limiting. Because the nappy area is spared in eczema and involved in most of the alternatives, that single observation resolves a surprising number of cases at home.
Probably discoid eczema — well-defined round or oval plaques, often on the limbs, that itch intensely and are frequently mistaken for ringworm.
Read the full answerHide the full answer
Discoid or nummular eczema produces distinctly circular patches, typically one to several centimetres across, most often on the lower legs, forearms and backs of the hands. They may weep and crust early on and become dry and scaly later, and they itch considerably. The look-alike that matters is ringworm, which is also round but tends to clear in the centre while advancing at the edge, and which gets substantially worse if treated with a steroid — so a circular patch that expanded after steroid treatment deserves reassessment rather than a stronger steroid. Discoid eczema is stubborn: it often needs a more potent steroid than its size suggests, applied for longer than people expect, and it relapses in the same spots. It is also strongly associated with dry skin and cold weather, and in adults it warrants a look for contributing factors including contact allergy and, occasionally, alcohol intake. Persistent single patches that never resolve should be examined rather than treated indefinitely at home.
Could this be a reaction to something rather than eczema? #
If the patch matches the shape of something touching it, or appeared after a new product, contact dermatitis is likelier — and it will not settle until the contact stops.
Read the full answerHide the full answer
Contact dermatitis and eczema look similar under a lens and behave completely differently in practice. The tell is geometry and history. A rash tracing a watch strap, a waistband, the shape of a plaster, the edge of a glove, or the exact area a product was applied is a contact reaction. So is one that appeared within days to weeks of a new cosmetic, hair dye, jewellery, work material or medication — including, awkwardly, the creams being used to treat eczema. The delay is what fools people: allergic contact dermatitis typically appears twenty-four to seventy-two hours after exposure, so the culprit rarely feels recent. Two further hints are worth having. Eczema that suddenly stops responding to treatment that used to work is a classic presentation of a contact allergy layered on top of it. And hand and eyelid rashes have a particularly high rate of contact causes. Patch testing is the way to identify it, and no amount of emollient or steroid resolves it while the exposure continues.
Could this be a fungal infection rather than eczema? #
Suspect fungus when a patch is one-sided, has a raised advancing edge with a clearer centre, or got noticeably worse after a steroid cream.
Read the full answerHide the full answer
Tinea and eczema are confused constantly, and the consequences run one way: steroids suppress the inflammation that makes ringworm visible while letting the fungus spread, producing a spreading, oddly indistinct rash known as tinea incognito. Three features point away from eczema. Asymmetry — fungal infection is often confined to one foot, one hand, one side of the groin, while eczema tends to be more symmetrical. An active raised scaly border with a flatter centre. And a history of improving on a steroid then worsening, or of never quite responding. Feet and groin involvement together, or nail thickening alongside a hand rash, both raise the odds substantially. Confirmation is easy and worth having: skin scrapings examined or cultured settle it, and treatment then diverges completely, since fungal infection needs an antifungal and eczema needs anti-inflammatory treatment. If you have been applying a steroid to a rash for weeks with no benefit, that is the moment to ask rather than escalate potency.
Itch is the dividing line. Dry skin is rough and tight; eczema itches, comes in defined patches, and flares and settles rather than staying constant.
Read the full answerHide the full answer
Dry skin is a state of the whole surface — uniformly rough, tight after washing, occasionally flaking, and it responds within days to moisturiser. Eczema is an inflammatory condition with a different signature: it appears as defined patches rather than an overall texture, it itches persistently and often worst at night, the skin is thickened or leathery where it has been scratched over time, and it cycles through flares and quieter periods. Location helps. Eczema favours the insides of the elbows and backs of the knees in older children and adults, the face and outer limbs in infants, and the hands in adults with occupational exposure. Weeping, crusting or small blisters put it firmly outside simple dryness. The practical distinction matters because the treatment ceiling differs. Moisturiser alone genuinely fixes dry skin. For eczema, moisturiser is the foundation and often not sufficient on its own — something anti-inflammatory is usually needed to settle an active patch, and no quantity of cream substitutes for it.
Eczema itches more and has blurred edges; psoriasis has sharply defined plaques with thick silvery scale, and favours elbows and knees on the outside rather than the creases.
Read the full answerHide the full answer
Four features usually separate them. Itch: intense and dominant in eczema, present but often secondary to soreness in psoriasis. Edges: eczema patches fade into normal skin, psoriasis plaques stop abruptly at a clear border. Scale: psoriasis produces thick, adherent, silvery-white scale that leaves pinpoint bleeding if picked off, while eczema scale is finer and often accompanied by weeping or crusting during a flare. Distribution: psoriasis prefers the outside of elbows and knees, the scalp, the lower back and the navel; eczema prefers the inside of elbows and knees, the neck, the hands and the eyelids. Two extra clues favour psoriasis strongly — nail pitting or separation, and any joint pain or stiffness, which needs mentioning because psoriatic arthritis benefits from early treatment. Overlap exists and a biopsy is occasionally needed. The distinction matters practically: emollient volume is the foundation for eczema, while psoriasis leans on vitamin D analogues and has a different escalation ladder.
Hand rashes are eczema more often than not, but the type matters — irritant, allergic and dyshidrotic hand eczema have different triggers and different fixes.
Read the full answerHide the full answer
Hands are the most exposed skin on the body and the most common site of adult eczema, but the label alone does not tell you what to do. Irritant hand eczema comes from repeated wet work, soap, solvents and friction, and it dominates in healthcare, catering, cleaning, hairdressing and childcare — the skin dries, cracks and splits across the knuckles and fingertips. Allergic hand eczema follows a specific sensitiser and often affects the fingertips or the backs of the hands in a pattern matching contact. Dyshidrotic eczema produces intensely itchy deep-seated blisters like tapioca along the sides of the fingers and palms, often in crops. Two things need excluding: fungal infection, which is usually one-handed and often accompanied by foot involvement, and psoriasis, which produces thicker, better-defined palm plaques. Because occupational exposure and contact allergy are so common here, hand eczema that persists despite decent treatment is one of the clearest indications for patch testing.
No. Eczema is substantially inherited, and nothing you did during pregnancy, feeding or in the first months created it.
Read the full answerHide the full answer
Parents are handed an enormous amount of blame for this condition, almost all of it unfounded. The strongest predictor of a child having eczema is family history — a parent or sibling with eczema, asthma or hay fever — and inherited barrier gene variants sit behind a large share of cases. What has not been shown to cause eczema: how you fed your baby, bathing habits, using or not using a particular cream, household cleanliness, or a mother's diet during pregnancy or breastfeeding. Restricting a mother's diet is specifically not recommended and carries nutritional risk. Two things do have evidence and are worth knowing because they are actionable rather than accusatory: treating eczema early and well is associated with better outcomes, and delaying allergenic foods is now understood to be the wrong instinct. If guilt is driving decisions in your household, it is worth saying plainly that it is misplaced — and that the energy is better spent on the emollient quantities, which are the part that genuinely changes the course.
In a minority — mostly infants and young children with moderate to severe eczema. In adults it is uncommon, and elimination diets more often cost than help.
Read the full answerHide the full answer
Food-triggered eczema is real but far rarer than the internet implies. It is most plausible in a baby or young child with moderate to severe eczema that resists good treatment, where cow's milk, egg, peanut, wheat or soy may contribute, and where the pattern is reasonably reproducible. In adults, genuine food-driven eczema is uncommon. Two failure modes are worth avoiding. Testing without a clinical story: blood and skin-prick tests detect sensitisation, which is common and frequently irrelevant, so a long list of positives usually generates anxiety rather than answers. And self-directed elimination, which carries real nutritional risk in children, can precipitate genuine food allergy on reintroduction after a long avoidance, and consumes the attention that emollient dosing needs. The reasonable path is a supervised trial: remove one suspected food for a defined period with dietetic input, reintroduce, and observe. Immediate reactions — hives, swelling, vomiting or breathing difficulty within minutes of a food — are a different and urgent matter entirely.
Living in a hard-water area is associated with more eczema, particularly in infants — but the softener trial did not show a treatment benefit once eczema exists.
Read the full answerHide the full answer
Epidemiology links hard water to higher eczema prevalence, and the mechanism is plausible: calcium and magnesium react with soap to leave a residue, raise skin surface pH and appear to increase barrier permeability, with some evidence that this matters most in people carrying filaggrin variants. The intervention question is separate, and the answer is more sobering. A large UK randomised trial of domestic water softeners in children with eczema found no significant benefit over usual care. So the association is real while the fix, at least in that form, is not established — which is worth knowing before spending on installation. What remains sensible costs little: use a non-soap cleanser, since soap plus hard water is the combination that leaves residue, keep washing brief and lukewarm, rinse thoroughly, and apply emollient immediately afterwards. If you have moved to a hard-water area and skin deteriorated, adjust the cleansing routine before adjusting the plumbing.
Yes, more convincingly than for most skin conditions — stress hormones alter both barrier repair and immune signalling, and the itch-scratch cycle amplifies it.
Read the full answerHide the full answer
The link here is better established than the equivalent claim in other conditions. Experimental work shows psychological stress slowing recovery of the skin barrier, and stress hormones modulate exactly the immune pathways that drive eczema. Layered on top is behaviour: scratching increases under stress, often unconsciously, and each scratching episode damages the barrier and releases mediators that provoke more itch. Sleep loss from itching then feeds the stress, which is why flares so often arrive as a spiral rather than an event. What follows is not an instruction to relax, which nobody has ever managed on request. It is that the mechanical parts of the plan matter most precisely when life is hardest — keeping the emollient going, starting the anti-inflammatory early rather than waiting, and protecting sleep. Habit-reversal techniques for scratching have a genuine evidence base in eczema, and psychological support alongside dermatological treatment produces better skin outcomes, not merely better mood.
They can aggravate existing eczema in sensitised people, but removing them rarely clears it — and the expensive interventions have disappointing trial results.
Read the full answerHide the full answer
House dust mite allergen is a plausible aggravator in people who are sensitised to it, and some do notice a difference with reduced exposure. What the evidence does not support is the industry built around it: trials of mite-proof bedding covers, high-filtration vacuuming and acaricide sprays have generally failed to produce meaningful improvement in eczema, individually or combined. Pets are similar — a genuine trigger for a minority, and rehoming a family animal is a large decision to make on weak evidence, so a period of restricting the animal from bedrooms is a more proportionate test. What is worth doing regardless is cheap: wash bedding at a high temperature weekly, keep bedrooms cool and reasonably ventilated since heat and sweating provoke itch, and reduce soft furnishings in a child's sleeping area if it is easy to do. Approach the whole category as marginal gains around a treatment plan, and be sceptical of anything expensive sold as an eczema solution.
No. Eczema is an inflammatory skin condition that makes allergies more likely, not an allergic reaction to something you can find and remove.
Read the full answerHide the full answer
The distinction is the single most useful thing to understand about this condition, because the alternative belief sends people on years of elimination hunts. Eczema is driven by a barrier defect plus immune over-reactivity. Allergies frequently accompany it — food allergy, asthma and hay fever cluster with eczema in what is called the atopic march — but they travel alongside it rather than causing it. Current understanding runs the other way round: a damaged barrier allows allergens to be encountered through the skin, and that sensitisation route is thought to contribute to developing allergies in the first place, which is part of why early, effective eczema treatment in infancy matters. Allergens can certainly aggravate existing eczema, and identifying a genuine trigger is worthwhile when the pattern is consistent. What does not work is treating eczema as an allergy to be found: most people never identify a single culprit, positive blood or skin tests frequently indicate sensitisation rather than clinically relevant allergy, and the search delays the treatment that works.
A leaky skin barrier and an over-reactive immune system, both largely inherited. The barrier lets irritants and allergens in; the immune system over-responds to them.
Read the full answerHide the full answer
Two mechanisms drive it together, which is why single-target explanations always disappoint. The barrier half is structural: many people with eczema carry variants in the filaggrin gene, which builds a key protein of the outer layer, and the result is skin that loses water outwards and admits irritants, allergens and microbes inwards far more readily than it should. The immune half is a type 2 inflammatory response that fires disproportionately at what gets in, producing the itch, redness and swelling. Each worsens the other: inflammation degrades the barrier further, and a worse barrier admits more triggers. That loop explains the treatment logic exactly. Emollients repair and substitute for the barrier and are used permanently. Anti-inflammatories interrupt the immune half and are used to regain control. Neither replaces the other, which is why moisturiser alone stalls in moderate disease and why steroid alone leads to endless relapse. Environment modulates all of it — climate, water hardness, irritants, infection — but it is acting on an inherited susceptibility.
Oversimplified “Natural oils and herbal creams are gentler than medical emollients.”
Not reliably. Coconut and sunflower oil have some support, but olive oil measurably damages the barrier and essential oils are a common cause of contact allergy.
Read the full answerHide the full answer
This category deserves specificity rather than a blanket verdict, because the members behave very differently. Sunflower seed oil has evidence for supporting barrier lipid production, and virgin coconut oil has small trials showing benefit including reduced staphylococcal colonisation. Olive oil, widely recommended for infant skin, has been shown in controlled work to damage the stratum corneum and worsen barrier function, and guidance has moved away from it. Essential oils, tea tree included, are among the more frequent causes of allergic contact dermatitis and are a poor idea on skin whose defining feature is heightened permeability. Herbal creams sold for eczema have repeatedly been found to contain undeclared potent steroids, which is the opposite of what the buyer intended. The useful frame is that a bland, boring, fragrance-free emollient used in large quantities beats an interesting one used sparingly — and that the word natural on a label carries no information about irritancy, which is the property that actually matters here.
Oversimplified “Bleach baths are a proven treatment every eczema patient should be doing.”
They probably help moderately, but trials comparing them with plain water baths mostly found no advantage — much of the benefit may be the bathing itself.
Read the full answerHide the full answer
Dilute sodium hypochlorite baths were adopted on the reasoning that reducing staphylococcal load on eczematous skin should reduce inflammation. The evidence has been genuinely mixed. A 2022 systematic review and meta-analysis concluded bleach baths probably improve severity with moderate certainty. An earlier meta-analysis found that although bleach baths reduced severity, they were not significantly better than plain water baths — which suggests regular bathing followed by emollient is doing a good share of the work. Practical points if you try them: the concentration is small, roughly a quarter to half a cup of standard household bleach in a full bath, never applied undiluted; sessions run five to ten minutes, twice weekly; and emollient goes on immediately afterwards. Stinging and burning are common on broken skin, and asthma flares have been reported. They are an adjunct for eczema that is repeatedly infected, not a substitute for anti-inflammatory treatment, and worth agreeing with a clinician rather than improvising.
Does having eczema mean my home or habits aren't clean? #
Not true “Eczema is a sign of an unclean home or poor personal hygiene.”
No, and the opposite is closer to true — over-washing and harsh cleaning products damage the barrier that eczema has already compromised.
Read the full answerHide the full answer
Eczema attracts a hygiene accusation that has no basis, and it lands hardest on parents, who are frequently made to feel that visible eczema in a child signals neglect. The condition is driven by inherited barrier and immune factors; a spotless house does not prevent it and a chaotic one does not cause it. Where cleaning genuinely intersects is in the opposite direction. Soap, detergents, antibacterial washes, disinfectant wipes and frequent hot washing all strip lipids from skin that cannot afford to lose them, so households responding to eczema by cleaning more aggressively often make it worse. There is also a broader observation worth knowing: eczema is more common in high-income, urbanised populations, not less, which is difficult to square with dirt as a cause. What helps is unglamorous — non-soap cleansers, gloves for household chores, fragrance-free laundry products, and heavy emollient use. If someone implies otherwise about you or your child, they are repeating folklore.
Is the scratching causing the eczema, or the other way round? #
Partly true “If you could just stop scratching, the eczema would clear up.”
Both. Eczema itches, scratching damages the barrier and releases mediators that provoke more itch — and breaking that loop is a treatment target in its own right.
Read the full answerHide the full answer
The itch-scratch cycle is not a figure of speech. Inflamed skin generates itch through nerve fibres sensitised by immune mediators; scratching provides brief relief by overriding the itch signal, while mechanically damaging the barrier, releasing more inflammatory mediators, and lowering the threshold for the next itch. Over time repeated scratching thickens skin into leathery lichenified plaques that itch more than the original patch did, which is why long-standing eczema often has a worst spot that is worst precisely because it has been scratched most. Scratching also happens during sleep, unconsciously, which is why people wake with fresh damage they do not remember causing. What follows practically is that treating itch is treating eczema, not managing a symptom. Effective anti-inflammatory treatment reduces itch at source; emollient reduces the dryness component; habit-reversal techniques, cool compresses, short nails and overnight cotton gloves address the mechanical half. Sedating antihistamines help sleep rather than itch, which is a real but narrow use.
Mostly untrue “Eczema is a childhood condition that everyone grows out of.”
No. Many children improve, but a substantial number carry it into adult life, and eczema also begins for the first time in adults and older people.
Read the full answerHide the full answer
The reassurance that a child will grow out of it is offered constantly and is only partly accurate. A good proportion do see substantial improvement by adolescence, but a meaningful minority continue to have eczema as adults, and studies following children into later life find persistence higher than the folklore suggests. Adult-onset eczema is a separate and under-recognised category, arriving in people with no childhood history — sometimes triggered by occupational exposure, sometimes by a change in circumstances, sometimes for no findable reason. It is also increasingly recognised in older adults, where dry skin, medication and a changing immune profile all contribute. The practical consequences of the myth are two. Adults presenting with new eczema are sometimes told they cannot have it, which delays treatment. And older children are told to wait rather than be treated, which is exactly the group where sleep, school and self-esteem are being affected. New or persistent eczema at any age is worth treating properly rather than waiting out.
Not true “Eczema is catching — keep children with it away from others.”
No. Eczema cannot spread between people by any route — not touching, not sharing a bed, not a swimming pool, not weeping skin.
Read the full answerHide the full answer
Eczema is a disorder of your own barrier and immune system, and there is nothing transmissible about it. The belief persists more stubbornly than for other skin conditions because eczema can look alarming during a flare — weeping, crusted or broken skin reads as infection to people who have not seen it before — and because children with visible eczema are still occasionally excluded from swimming lessons, sleepovers or nurseries by adults acting on that assumption. That exclusion is not medically justified and is worth pushing back on, calmly and once, with a note from a clinician if needed. Two clarifications so the answer is honest. Eczematous skin can become infected, and those infections — bacterial or herpes simplex — are themselves transmissible, so a child with actively weeping, golden-crusted or blistering skin should be seen and may need to avoid close contact briefly. And eczema does run in families, which people sometimes misread as spreading between them. That is shared genetics, not contagion.
Mostly untrue “Eczema is just dry skin, so the answer is a better moisturiser.”
No. Dryness is one visible half; the other is inflammation, and that is the half moisturiser cannot reach when a patch is active.
Read the full answerHide the full answer
Treating eczema as extreme dryness is the single most common reason people plateau. Emollients are genuinely first-line and they do the heavy lifting — they repair and substitute for the barrier, reduce flare frequency, and reduce how much steroid is needed over a year. What they cannot do is switch off an active inflammatory patch, because the immune half of the condition is not a moisture problem. So the pattern of someone applying more and thicker cream to an angry, weeping patch, and concluding that eczema is untreatable when it does not settle, is a category error rather than a product failure. The working model is two jobs running in parallel: emollient constantly, everywhere, including on skin that looks fine, forever; and something anti-inflammatory, promptly and at adequate strength, when a patch is active, stopped when it settles. People who understand that division stop cycling through moisturisers looking for the one that works, which is the search this misconception generates.
Partly true “Topical steroids are addictive and cause withdrawal, so avoid them entirely.”
A withdrawal reaction after prolonged potent steroid use is recognised, though evidence is thin and contested — and fear of it drives far more undertreated eczema than the syndrome itself.
Read the full answerHide the full answer
Regulators including the UK's MHRA have reviewed the topic and accept that a withdrawal reaction can follow prolonged, uninterrupted use of moderate-to-potent topical steroids, typically after months of continuous application, and most often on the face and genital skin. It presents as burning skin pain rather than the usual itch, spreading redness beyond the treated area, and shedding, appearing days to weeks after stopping. What the literature does not yet have is agreed diagnostic criteria, reliable incidence figures, or trial-quality evidence, and reviews describe a striking gap between the volume of online discussion and the published base. Both halves matter. Anyone whose skin is burning after stopping a long steroid course deserves to be believed and assessed rather than dismissed. And the far commoner harm in practice is the opposite one: people so frightened by what they have read that they undertreat active eczema for years, which carries its own costs in sleep, infection and scarring. Intermittent use as directed, with breaks, is not the pattern associated with withdrawal.
Should I leave eczema uncovered to let it breathe? #
Not true “Eczema heals faster if you let the air get to it.”
No. Skin does not breathe, and an uncovered, un-moisturised patch loses water faster, itches more and heals more slowly.
Read the full answerHide the full answer
The instinct comes from wound care folklore and gets the physiology backwards. Skin takes its oxygen from the blood supply beneath, not from the air above it, so exposure confers no benefit. What exposure does is accelerate transepidermal water loss from skin that is already leaking, and dry skin itches more, which produces more scratching and more damage. Moist wound healing is the established principle for a reason: covered, occluded skin repairs faster. In eczema this is why the most effective emollients are the greasiest ointments, why applying immediately after bathing traps water in the skin, and why wet wrapping — damp bandaging over emollient — is used deliberately in severe flares. Two genuine exceptions keep the answer honest. Weeping, infected skin sometimes needs drying measures and antimicrobial treatment rather than heavy occlusion. And overheating provokes itch, so occlusive layers on a hot night can backfire. Otherwise: cover it, grease it, and stop letting it dry out.
Will cutting out dairy or gluten clear my eczema? #
Mostly untrue “Cutting out dairy and gluten clears eczema.”
For most people, no. Elimination diets show little benefit in unselected eczema, and they carry real nutritional and allergy risks in children.
Read the full answerHide the full answer
Reviews of exclusion diets in people with eczema who are not known to be food allergic have found little to no benefit, and the reasoning is the one that governs the whole condition: eczema is a barrier and immune disorder rather than a reaction to a food. Two specific harms make casual elimination worse than neutral. In children, restricting staple food groups risks inadequate calcium, protein and calories at a time of rapid growth. And prolonged avoidance of a food someone was previously tolerating can lead to genuine IgE-mediated allergy on reintroduction, including severe reactions — a documented pattern with milk and egg. The version that is worth doing is supervised, targeted and time-limited: one suspected food, removed for a defined window with dietetic support, then formally reintroduced. If eczema is severe in a young child and treatment is optimised without control, food investigation is a reasonable next step through an allergy service. Doing it first, unsupervised, is the sequence that costs.
Which active, what strength, how much, what order, contact time, how long before judging it, what to stop using.
Do I need different products for my face and body? #
Same emollient is usually fine; the steroid is not. Facial skin is thinner and needs a milder potency or a non-steroid alternative for anything beyond short courses.
Read the full answerHide the full answer
Emollients rarely need splitting — the main reason people use a lighter one on the face is cosmetic, since ointment under makeup or before work is unpopular, and that is a legitimate reason rather than a clinical one. Anti-inflammatory treatment is where the distinction becomes real. Facial and eyelid skin absorbs far more of an applied steroid than forearm skin, so the same tube that is appropriate on a limb can cause thinning, visible vessels or perioral dermatitis on the face within weeks. That is why clinicians reach for mild potencies there, keep courses short, and frequently prefer a topical calcineurin inhibitor such as tacrolimus, which carries no thinning risk and is specifically useful around the eyes. Eyelid eczema deserves particular care and a low threshold for asking, since it is also a common site for contact allergy from products applied to the hair, nails or face. As a rule: one emollient everywhere, and never move a body steroid onto your face because you have it in the cupboard.
Largely no. A big randomised trial in children found bath additives added no meaningful benefit on top of standard leave-on emollients.
Read the full answerHide the full answer
The BATHE trial randomised nearly 500 children with eczema to emollient bath additives plus usual care, or usual care alone, and found no clinically important difference in eczema severity over a year. That result has changed prescribing in several countries, and it is a rare example of a well-designed trial removing something from routine practice rather than adding it. The reasoning is intuitive once stated: an additive dispersed in a whole bath contacts the skin briefly and mostly goes down the drain, whereas a leave-on emollient stays on for hours. Two caveats keep it honest. The trial studied children, and it examined additives specifically, not bathing itself — bathing followed promptly by emollient remains useful. And some people genuinely find an oil makes the water less drying and the experience more comfortable, which has value even without a severity benefit. If money is limited, spend it on leave-on emollient in bulk rather than on bath products, and be wary of oils making the tub dangerously slippery, particularly for children and older adults.
Do colloidal oatmeal and ceramide products actually do anything? #
Both have reasonable supporting evidence — ceramides for barrier repair, colloidal oatmeal for itch and irritation — though neither outperforms plain generous emollient use dramatically.
Read the full answerHide the full answer
Ceramides are structural lipids of the outer skin layer and are measurably depleted in eczematous skin, so replacing them is mechanistically sensible; studies of ceramide-containing emollients show improvement in barrier function and severity, and they are a reasonable choice. Colloidal oatmeal has anti-inflammatory and anti-itch properties attributed to its avenanthramides, holds a recognised regulatory status as a skin protectant in the US, and has small trials supporting reduced itch and improved barrier measures. Both are worth choosing when the price is similar. What the evidence does not support is treating either as a category apart — an expensive ceramide cream applied sparingly loses to a basic emollient applied properly, and the effect size differences between decent emollients are small next to the difference between using 100 g a week and 400 g. Choose one of these if it is affordable at volume and you find it pleasant, and judge it over four to six weeks rather than days.
Stinging usually means the skin underneath is inflamed or broken, not that the product is wrong — though propylene glycol and urea sting predictably on damaged skin.
Read the full answerHide the full answer
Two explanations cover almost all of it. The first is that inflamed, fissured skin has exposed nerve endings and a compromised barrier, so almost anything applied stings — and the remedy is to treat the inflammation, at which point the same emollient becomes comfortable within days. Switching product repeatedly at this stage is the common misstep, because it looks like a formulation problem and is not. The second is genuine ingredient irritancy: propylene glycol, urea, lactic acid and some preservatives sting reliably on broken skin even though they are useful on intact skin, and fragrance stings and sensitises. So the sequence is: switch to a bland ointment with a minimal ingredient list, get the anti-inflammatory treatment onto the active areas properly, and reintroduce your usual emollient once the skin is closed. Persistent stinging from a product on skin that is otherwise settled, particularly with itching and spreading redness, points at allergic contact dermatitis to an ingredient and is worth patch testing rather than tolerating.
By weight, not by feel. An adult treating widespread eczema needs roughly 250–500 g a week; if a 500 g tub lasts a month, you are using a fraction of the dose.
Read the full answerHide the full answer
Quantity is the single most under-recognised variable in eczema, and the only reliable way to check it is arithmetic. Guideline figures for an adult with widespread eczema run to 250–500 grams a week, and 100 grams a week for a child, applied to the whole skin surface rather than to patches. Set against that, a 500 gram tub lasting a month means roughly a quarter of the intended dose. For medicated creams the fingertip unit is the equivalent measure: a line of cream squeezed from the tip of an adult index finger to the first crease treats an area about the size of two flat adult hands, and a whole adult body takes around forty of them. Two consequences follow. Ask for emollient prescriptions by quantity rather than accepting whatever appears, since supply frequently sets the ceiling on use. And when a treatment appears to have failed, weigh the tube before concluding anything — inadequate quantity looks identical to an ineffective product, and it is far more common.
Do I put moisturiser on before or after the steroid? #
Either order works — leave a gap of roughly twenty to thirty minutes between them so one does not dilute or spread the other.
Read the full answerHide the full answer
This question generates a surprising amount of contradictory advice, and the honest answer is that the sequence matters less than the separation. Applying both at once can dilute the steroid and spread it onto skin that does not need it, which is the practical concern rather than any loss of potency. Guidelines and dermatology departments differ on order and generally recommend leaving a gap and applying whichever suits your routine first. A workable pattern for most people: emollient after the shower, steroid to the active patches half an hour later, emollient everywhere again at bedtime. What matters more than the order is that both are actually happening — the common failure is the emollient quietly stopping while a flare is being treated, so the moment the steroid stops the skin has nothing underneath it. Apply the steroid only to the inflamed areas and the emollient to everything, and if you are counting, the emollient should be running out several times faster than the steroid.
Ointment is the most effective and the least pleasant; lotion is the most pleasant and the least effective. Most people do best with ointment at night, cream by day.
Read the full answerHide the full answer
The three differ by how much oil they contain and therefore how well they seal water into the skin. Ointments are largely oil, contain little or no water, need few or no preservatives, and hold moisture best — which also makes them greasy, slow to absorb and unpopular, and unsuitable under clothing for some people. Creams balance the two and suit daytime use. Lotions are mostly water, spread easily and evaporate quickly, and are the weakest option for eczema, though they are the most practical for hairy areas and large surfaces. There is a well-documented pattern of people selecting on feel and quietly moving down the scale until the emollient no longer does much, then concluding emollients do not work. Two useful compromises: use the ointment overnight when greasiness costs nothing, and reserve creams and lotions for daytime and hot weather. If ointment stings on broken skin, that is a reason to treat the inflammation rather than to switch to something thinner.
Yes for a short course on a small area of mild eczema. It is genuinely useful and genuinely too weak for the face, folds, or anything lasting more than a week or two.
Read the full answerHide the full answer
Hydrocortisone 1% is the one active drug in the eczema aisle, and it works within its limits. Those limits are worth knowing precisely. It is a mild-potency steroid, suited to small patches of mild eczema on the body, used once or twice daily for up to about seven days. Package instructions typically restrict use on the face and around the eyes, in the genital area, and in young children without medical advice — and those are exactly the situations people most often use it in. Where it commonly fails: moderate eczema, where a mild steroid simply cannot break the flare and repeated inadequate courses waste weeks; thick lichenified patches, which need more potency; and anything infected. The practical rule is that if a week of correct use with generous emollient has not clearly settled the patch, the answer is a clinician rather than another week of the same tube. Using it below the strength the situation needs is undertreatment, and it is more common than overuse.
A soap substitute or a non-foaming cleanser. Ordinary soap raises skin pH and strips lipids, which is precisely the damage eczema already has.
Read the full answerHide the full answer
Traditional soap is alkaline, and healthy skin sits at a mildly acidic pH that supports both barrier enzymes and the resident microbiome. Raising that pH impairs barrier repair and favours staphylococcal growth, which is why soap reliably worsens eczema and why the first change worth making is abandoning it. Options are a syndet or pH-balanced non-soap bar, a fragrance-free liquid cleanser, or using a leave-on emollient as a wash. Foam is the property to distrust — heavy lathering usually means surfactants that strip. Skip antibacterial washes, which offer no benefit in ordinary eczema and add irritancy, and skip anything scented, including bubble bath for children, which is a common and easily removed aggravator. Practical notes: wash only where needed rather than lathering the whole body daily, keep water lukewarm, and apply emollient within a few minutes of getting out. Hands need their own plan, since hand-washing frequency is usually non-negotiable — a cleanser at the sink and emollient beside it is the version that survives a working day.
At least twice daily regardless of how skin looks, always within minutes of bathing, and more often on hands and any area that feels tight.
Read the full answerHide the full answer
Timing carries more weight here than in most routines. The highest-value application is immediately after a bath or shower, within about three minutes, while the outer layer is still hydrated — pat rather than rub dry, then apply generously to trap that water. Beyond that, a floor of twice daily every day, extended to four or more times on hands, and topped up whenever skin feels tight, which is the earliest signal of a barrier losing ground. The rule most often broken is applying only to visible patches during a flare: emollient works preventively, and skin that looks fine is where the next flare is forming. Two practical notes. Apply in downward strokes following the direction of hair growth rather than rubbing in circles, which reduces the risk of blocking follicles and provoking folliculitis. And keep a tub at work, in the car and by the bed, because the applications that get skipped are the ones requiring a trip upstairs.
The greasiest one you will genuinely use in large amounts, fragrance-free, in a big tub. Brand matters far less than quantity and how often it goes on.
Read the full answerHide the full answer
Trials comparing emollients against each other rarely find a clear winner, and the reason is that the variable driving outcomes is not formulation but volume. So choose on the properties that determine whether you will use enough: it must be fragrance-free, it must be affordable in the quantities eczema actually requires, and it must feel tolerable enough on your skin that you will apply it several times a day for years. Beyond that, greasier is more effective — ointments outperform creams, which outperform lotions — and the sensible compromise most people land on is an ointment overnight and a cream during the day. Ingredients worth having are ceramides, glycerin and petrolatum; ingredients worth avoiding are fragrance, essential oils and, in some products, methylisothiazolinone. Buy the largest size available, keep tubs in more than one room, and treat running out as the emergency it actually is. A perfect cream used twice a week loses to an ordinary one used four times a day.
Realistic timelines, getting worse before better, purging versus reacting, how to judge without changing everything, when to call a trial failed.
Am I actually getting better, or does it just feel that way? #
Track itch and sleep, not appearance. Both improve before the skin looks better, and both matter more to how you actually feel.
Read the full answerHide the full answer
Appearance is the slowest and least reliable measure. Colour changes lag, and in deeper skin tones redness is a poor guide at the best of times, so judging by looks alone underestimates progress and overestimates severity. Two better measures are available and both are free. Itch, scored simply out of ten each evening, responds early to effective treatment and is what the whole condition costs you. Sleep — how many nights disturbed in the past week — is the single most useful number to bring to an appointment, because it captures severity in a way a photograph cannot and it is the outcome clinicians act on. Add photographs in consistent light every couple of weeks for the appearance component, particularly for thickened patches whose change is gradual. Reassess at two weeks for a flare and at eight to twelve for a maintenance regimen. If itch and sleep have not improved after two weeks of correct treatment, that is a concrete thing to report rather than a vague sense that it is not working.
With adequate treatment, most flares improve within a few days and settle in one to two weeks. Longer than that means the treatment is too weak, too little, or the diagnosis is wrong.
Read the full answerHide the full answer
A flare treated properly moves quickly, and that speed is diagnostically useful. Applied at adequate potency and quantity, a topical steroid usually produces visible improvement within three to five days and settles a typical flare within one to two weeks. When that does not happen, run through the likely reasons before escalating blindly. Quantity is the first — most people apply a fraction of what is needed, and the fingertip unit measure exists because eyeballing it systematically under-doses. Potency is the second: a mild steroid on a moderate flare will simply hold it steady. Then infection, which stalls a flare and usually brings weeping, golden crusting or pain. Then a continuing trigger — a contact allergen, an occupational exposure — that treatment cannot outrun. And finally the diagnosis itself, since fungal infection and other look-alikes worsen on steroid. Two weeks of correct use without meaningful change is the point to go back rather than continue, and that is a reasonable thing to say plainly at an appointment.
Until the patch is genuinely settled — not itchy, not raised — which is usually longer than it looks. Stopping the moment redness fades is the classic cause of immediate relapse.
Read the full answerHide the full answer
Most people stop too early rather than too late. Visible redness fades before the underlying inflammation has resolved, so treatment abandoned at the first sign of improvement leaves an active patch that flares again within days, producing the pattern of endless short courses that never quite work. Standard guidance is to continue daily until the skin is smooth and no longer itchy, typically seven to fourteen days for a body flare, then stop or step down rather than tapering indefinitely. For skin that keeps relapsing in the same places, the better strategy is proactive treatment — applying the steroid to those known sites twice weekly once clear, which is recommended in guidelines and reduces flares substantially while using less steroid over a year than repeated rescue courses do. Emollient continues throughout and afterwards without interruption. If you are needing daily steroid for more than a couple of weeks, or repeatedly across months, that is not a reason to stop unsupervised — it is a reason to be reassessed for a step up.
Itch often improves within two to four weeks; skin clearance builds over three to four months. Judging it at week six understates what it will eventually do.
Read the full answerHide the full answer
Systemic treatments for eczema have a characteristic sequence worth expecting. Itch tends to respond first, sometimes strikingly, within the first few weeks — which matters, because itch is what costs sleep and quality of life. Visible skin improvement follows more gradually, with trial data showing continued gains out to sixteen weeks and beyond, and a proportion of people who look unimpressive at twelve weeks doing well by six months. That is why prescribers are reluctant to abandon a biologic early. Oral JAK inhibitors work considerably faster, often with meaningful itch reduction within days, which is one reason they are chosen when speed matters. Two practical points. Emollients and topical treatment continue alongside — a systemic drug is not a replacement for the foundation, and topical use usually falls sharply rather than to zero. And keep an itch and sleep record from before you start, because the change is gradual enough that people genuinely forget how bad it was.
My skin got worse after starting a new emollient — why? #
Three usual reasons: irritation from an ingredient, folliculitis from rubbing a greasy product in, or a genuine contact allergy developing to a preservative.
Read the full answerHide the full answer
New emollient followed by worse skin is common and usually explainable. Irritant stinging from propylene glycol, urea or an acid in the formula is the most frequent, appears immediately on application, and is worst on broken skin. Folliculitis — small pustules around hair follicles, particularly on the legs, chest and back — follows from rubbing thick ointment in circles, and resolves by applying in downward strokes along the direction of hair growth. Allergic contact dermatitis is the third, appears one to three days after use rather than immediately, itches rather than stings, and spreads beyond where the product went; preservatives such as methylisothiazolinone, along with lanolin and fragrance, are the usual culprits, and this pattern deserves patch testing. There is a fourth possibility worth naming: nothing to do with the emollient, since eczema flares on its own schedule and a new product often coincides. Introduce one product at a time and give it two weeks, which is the only way to attribute any of this reliably.
When should I go back if the treatment isn't working? #
Two weeks of correct use without clear improvement, or sooner if sleep is affected, the skin is infected, or you are frightened of the treatment.
Read the full answerHide the full answer
Set the threshold in advance so it does not drift. Two weeks of a properly applied topical regimen without meaningful improvement in itch and sleep is a real signal, and going back at that point is what the plan expects rather than an imposition. Go sooner for any of these: skin that is weeping, golden-crusted or painful, which suggests infection; a rash spreading rapidly or with fever; sleep lost several nights a week, which is the outcome most strongly linked to needing escalation; and treatment you are not using because you are worried about it, since undisclosed non-use looks identical to treatment failure and leads to escalation you may not need. Take three things: what you used, how much and for how long; how many nights of sleep were lost; and photographs of a bad day. That converts a vague report into something actionable. The next step is usually a stronger or different topical, patch testing, or a referral — not a repeat of what has already failed.
Why does it come back the moment I stop treatment? #
Because the treatment was controlling inflammation rather than curing it, and because it was probably stopped before the patch had fully settled.
Read the full answerHide the full answer
Eczema is a chronic relapsing condition, so return after stopping is expected rather than a sign of failure — but immediate return, within days, usually points at one of three fixable things. The course was stopped at the point redness faded rather than when the skin was genuinely smooth and itch-free, leaving live inflammation. The emollient stopped when the steroid did, removing the foundation that maintains remission. Or the underlying trigger has not changed, so the same exposure produces the same flare. The strategy that addresses all three is proactive maintenance: continue emollient permanently everywhere, and apply the anti-inflammatory to the historically worst sites twice a week even when they look clear. That approach is guideline-recommended and reduces relapse meaningfully. If flares still return within a fortnight of every course despite that, the honest conclusion is that topical treatment is not controlling the disease, and the next tier — phototherapy or systemic treatment — exists precisely for that situation rather than as a last resort.
They work fast and carry a boxed warning covering serious infection, clots, cardiovascular events and cancer — drawn largely from an older drug in rheumatoid arthritis patients.
Read the full answerHide the full answer
Oral JAK inhibitors are the fastest-acting systemic option for eczema, with itch reduction often within days, and that speed is genuinely valuable. The safety picture needs stating carefully. The class carries a boxed warning for serious infections, major cardiovascular events, blood clots, malignancy and death, derived principally from a large safety trial of tofacitinib in rheumatoid arthritis patients aged over fifty with cardiovascular risk factors — a population meaningfully different from a young adult with eczema. Data in eczema populations have so far been more reassuring, but the drugs are newer and long-term evidence is still accruing. What that means in practice: they require baseline and ongoing blood monitoring, screening for tuberculosis and hepatitis, attention to shingles risk with vaccination often recommended, and a considered discussion if you smoke, have cardiovascular risk factors, or a clot history. For younger patients without those factors, many clinicians regard the profile as acceptable — but this is a decision to make with information rather than to accept passively.
Yes, and it is under-recognised. Preservatives, lanolin and fragrance in emollients are common sensitisers, and eczema that stops responding is the classic clue.
Read the full answerHide the full answer
People with eczema apply large volumes of product to damaged, permeable skin over years, which is close to an ideal setup for developing contact sensitisation. The usual culprits are preservatives — methylisothiazolinone in particular, which caused a documented epidemic of contact allergy — along with lanolin, fragrance, and occasionally the corticosteroid molecule itself, which is genuinely possible and easily missed. The presentation is deceptive, because it looks like worsening eczema rather than a new problem: treatment that used to work stops working, the rash spreads slightly beyond the treated area, and it itches more than it stings. The consequence of missing it is escalation to stronger treatment that also fails. What to do: mention it explicitly, since eczema not responding to appropriate treatment is one of the clearest indications for patch testing, and the test covers steroid classes and preservatives. Meanwhile switch to the simplest ointment you can find, ideally preservative-free, which removes most of the candidate ingredients at once.
Narrowband UVB carries a much smaller risk than older PUVA, and studies have not shown a clear rise at typical course lengths — but lifetime session count is tracked for a reason.
Read the full answerHide the full answer
Narrowband UVB is the standard form used for eczema and has a considerably better safety profile than the older PUVA treatment, which combined a psoralen drug with UVA and does carry a documented, dose-related increase in squamous cell carcinoma. Long-term follow-up studies of narrowband UVB have not demonstrated a clear increase in skin cancer at the exposures used in ordinary treatment courses, though the accumulated evidence is not as long-running as anyone would like, which is why departments record your cumulative session count across your lifetime and factor it into decisions about repeat courses. Practical realities matter as much as the theoretical risk: treatment means attending a clinic two or three times a week for eight to twelve weeks, which is the reason most people who stop, stop. Eyes are shielded during sessions, genitals are covered, and photosensitising medication needs declaring. For people who cannot or prefer not to take systemic drugs, it remains a genuinely useful middle rung.
Conjunctivitis is the notable one, affecting a meaningful minority. Injection-site reactions and cold sores are the others; it does not suppress the immune system broadly.
Read the full answerHide the full answer
Dupilumab blocks a specific inflammatory pathway rather than suppressing immunity generally, which is why it does not require blood monitoring and why infection risk is not the concern it is with older systemic drugs. Its distinctive side effect is eye-related: conjunctivitis, dryness, itching and occasionally more significant inflammation, reported in a substantial minority of eczema patients and notably not in trials of the same drug for asthma, which remains an interesting unexplained finding. It is usually manageable with lubricating drops or a short course of eye treatment, sometimes needing an ophthalmologist, and rarely requires stopping. Other reported effects are injection-site reactions, cold sores, and a facial and neck redness that emerges in some people during treatment. Practical points: it is a self-administered injection, typically fortnightly after a loading dose; vaccinations should be discussed since live vaccines are generally avoided; and any new or persistent eye symptoms are worth reporting early rather than enduring, because they respond better treated promptly.
Real but dose-dependent and mostly local: thinning, stretch marks, visible vessels and acneiform eruptions, almost always after prolonged potent use on thin skin.
Read the full answerHide the full answer
The risks exist and are worth stating precisely, because vagueness is what fuels the fear. Local effects are the realistic concern: skin thinning, stretch marks, prominent small vessels, easy bruising, perioral dermatitis and steroid acne. These arise from continuous use of moderate-to-potent preparations over weeks to months, and they concentrate where skin is thin or occluded — the face, eyelids, genitals, armpits and groin. On the trunk and limbs, used intermittently as directed, a systematic review of long-term use found reassuring safety. Systemic absorption sufficient to suppress the adrenal axis is rare and confined to very potent preparations over large areas, particularly in infants, whose surface-area-to-weight ratio makes them more susceptible. Against all that sits the risk of undertreatment, which is not neutral: uncontrolled eczema means lost sleep, repeated infection, thickened skin and, in children, effects on growth and development. The rational position is to use enough, promptly, for as short a time as achieves control — not to minimise every application.
What does steroid-thinned skin actually look like? #
Skin that appears shiny, translucent and crinkled like tissue paper, with visible small vessels underneath and easy bruising — usually on the face or in a fold.
Read the full answerHide the full answer
Knowing the signs converts an abstract fear into something you can check. Atrophy presents as skin that has lost substance: shiny and slightly translucent, finely wrinkled like crumpled tissue, with the veins beneath more visible than on comparable skin elsewhere. Telangiectasia — fine red thread-like vessels — often accompanies it, along with bruising from minimal trauma. Stretch marks may appear where skin is stretched, typically in the armpits, groin and inner thighs, and these are the one change that is genuinely permanent. Around the mouth or eyes, a persistent crop of small red papules that flares when steroid is stopped suggests perioral dermatitis rather than atrophy. Two reassurances that follow from knowing what to look for: most atrophy from intermittent, appropriate use is reversible over weeks to months once the steroid stops, and if you cannot see any of these features after a normal course, they have not silently occurred. If you can see them, that is a specific thing to show a clinician rather than a reason to stop all treatment.
A burning or stinging sensation in the first week is expected with calcineurin inhibitors and usually fades. It is not damage, and pre-cooling the skin helps.
Read the full answerHide the full answer
Topical calcineurin inhibitors — tacrolimus ointment and pimecrolimus cream — commonly cause a burning, stinging or warm sensation for the first few applications, sometimes intense enough that people abandon them on day two. It typically settles within about a week as the underlying inflammation improves, and it is not a sign of harm. Several things reduce it: applying to skin that has been cooled, using it after a few days of a topical steroid so the skin is less inflamed to begin with, starting on alternate days, and avoiding alcohol, which can amplify facial flushing with these drugs. The trade is worth understanding, because these agents earn their place: they carry no risk of skin thinning, which makes them the preferred option for the face, eyelids and folds, and for long-term proactive maintenance where steroids would accumulate risk. The black-box cancer warning attached to them has not been supported by subsequent long-term data, and guidelines continue to recommend them.
Other actives, other prescriptions, oral medication, procedures, hair and body products, order of application.
Can I have vaccinations while on eczema treatment? #
Inactivated vaccines are fine on everything. Live vaccines are generally avoided on immunosuppressants and JAK inhibitors, and usually given before starting rather than during.
Read the full answerHide the full answer
The rule depends on which tier you are on. Emollients and topical treatments impose no restrictions at all. Dupilumab targets a narrow pathway and is not broadly immunosuppressive, though live vaccines are still commonly avoided as a precaution and non-live vaccines including influenza and COVID are recommended as normal. Conventional systemic drugs — ciclosporin, methotrexate, azathioprine — and oral JAK inhibitors are immunosuppressive, and live vaccines such as MMR, yellow fever, live shingles and live typhoid are contraindicated on them. That is why vaccination status is reviewed before starting: bringing everything up to date in advance, including shingles vaccination where relevant given the raised zoster risk with JAK inhibitors, avoids the problem entirely. Two practical points. Tell any clinician offering you a vaccine what you are taking, since it will not be obvious from a skin condition. And if you are travelling somewhere requiring a live vaccine, raise it early — the planning window is weeks, not days.
Not directly — eczema itch is not mainly histamine-driven, so non-drowsy antihistamines do little. Sedating ones help by aiding sleep, which is a narrower but real benefit.
Read the full answerHide the full answer
This is one of the most commonly prescribed things that does the least of what people expect. Eczema itch is driven by cytokines and nerve sensitisation rather than by histamine release, which is why non-sedating antihistamines such as cetirizine and loratadine perform poorly for it in trials, and why guidelines do not recommend them for the itch itself. Sedating antihistamines are a different proposition: they do not reduce itch either, but they induce drowsiness, and a night's sleep during a bad flare has genuine value. Used occasionally for that purpose, short-term, they are reasonable; used nightly for months they cause tolerance and daytime grogginess, and in children the evidence for routine use is poor. Where antihistamines genuinely earn their place is coexisting hives or hay fever, which many people with eczema also have. The effective way to reduce eczema itch is to treat the inflammation causing it — a properly dosed topical, or a systemic drug in severe disease, does what no antihistamine will.
Emollient first, let it settle, sunscreen last. Mineral formulas suit reactive skin better, and sunscreen matters more if you are having phototherapy or have pigment changes.
Read the full answerHide the full answer
Sunscreen is often abandoned by people with eczema because most formulas sting on compromised skin, which is a solvable problem rather than a reason to skip it. Sequence emollient first and give it fifteen minutes, then sunscreen as the outermost layer; applying it under a heavy ointment dilutes and displaces it. Mineral filters based on zinc oxide and titanium dioxide are generally better tolerated on inflamed skin than chemical filters, which are more likely to sting, and fragrance-free is non-negotiable. Two situations raise the stakes. If you are on phototherapy, the treated areas are deliberately exposed under supervision but everyday sun exposure still needs managing, and the face is often shielded during sessions. And post-inflammatory pigment change after eczema — darker or lighter patches — is aggravated by ultraviolet exposure, so sunscreen is what stops a settled flare leaving a mark for months. Sun itself is not a treatment: many people report improvement in summer, but burning provokes flares and the benefit does not justify deliberate exposure.
Do I need to stop eczema treatment before an operation? #
Topicals continue. Systemic immunosuppressants and JAK inhibitors are often paused around surgery because of infection and healing risk — that is a decision for the prescribing team.
Read the full answerHide the full answer
Say what you are taking at the pre-operative assessment, because a skin condition rarely gets asked about and the relevant drugs are not obvious. Emollients and topical steroids or calcineurin inhibitors continue as normal, though the surgical site itself will be cleaned and prepared, so apply nothing there on the day unless instructed. Systemic treatment is where planning is needed. Ciclosporin, methotrexate, azathioprine and oral JAK inhibitors affect immune function and wound healing, and teams commonly hold them for a defined window before and after surgery, weighing the risk of a post-operative complication against the risk of an eczema flare while off treatment. Dupilumab is generally regarded as lower risk and is often continued, but that is still the prescriber's call rather than an assumption to make. Two practical points: raise it weeks ahead rather than the night before, and ask specifically what to do if your skin flares badly during the pause, so you are not improvising in recovery.
Can I dye my hair or get a tattoo if I have eczema? #
Both are possible but carry a raised sensitisation risk. Never on broken skin, always with a patch test first, and black henna should be avoided outright.
Read the full answerHide the full answer
Damaged, permeable skin absorbs more of whatever is applied to it, which raises the chance of becoming sensitised. Permanent hair dye contains paraphenylenediamine, one of the most common causes of severe allergic contact dermatitis, and reactions on scalp and face skin can be dramatic. The manufacturer's allergy alert test is not optional here, and a scalp with active eczema should be settled first. Black henna temporary tattoos are worth a categorical warning: they contain high concentrations of the same chemical, cause severe reactions, and can leave permanent sensitisation that rules out hair dye for life. Permanent tattoos are generally done only on clear skin, since needling through an active eczema patch risks infection and the Koebner phenomenon, where trauma provokes new disease at the site; reputable artists will decline. Two practical alternatives: semi-permanent dyes without paraphenylenediamine, and asking a salon to apply a barrier along the hairline. Anyone already patch-test-positive to this chemical should treat all of the above as closed.
How long should I leave between different creams? #
Around twenty to thirty minutes between an emollient and a medicated cream. Applying them together dilutes the active and spreads it where it isn't needed.
Read the full answerHide the full answer
The practical concern is dilution and drift rather than any chemical incompatibility. Layering a medicated cream immediately onto a thick wet film of emollient reduces its concentration at the skin and carries it onto surrounding areas that do not need treating, which matters most for potent steroids on the face and folds. Twenty to thirty minutes is the usual advice and is enough for the first layer to absorb. In practice the workable pattern is to attach each application to something you already do — emollient after showering, medicated cream while the kettle boils, emollient again at bedtime — because a schedule requiring you to watch a clock is a schedule that gets skipped. Two additional notes. Apply the medicated product to the active patches only and the emollient everywhere, so the gap question mostly concerns a small area. And if you are using two prescription topicals, ask which goes where rather than assuming they layer: some are intended for different sites or on alternating days rather than stacked.
Can I use my child's eczema cream, or theirs on me? #
Emollients, yes. Steroids, no — potency is matched to the person, the site and the body area, and a child's face cream is not interchangeable with an adult's limb treatment.
Read the full answerHide the full answer
Emollients are freely interchangeable, and sharing a large tub across a household is sensible and economical — though use a clean spoon or a pump rather than dipping hands into a communal pot, since that introduces bacteria into a product that will sit on broken skin. Steroids are different. Potency is chosen for the person's age, the thickness of the skin being treated and the area involved, so an adult's moderate-potency ointment applied to a toddler's face can cause harm quickly, and a child's mild cream applied to an adult's thick lichenified plaque simply will not work, wasting a fortnight. Two further points. Prescription creams are dispensed with a quantity and a review attached; using someone else's means nobody is tracking how much you are getting through, which is the number that signals whether treatment is adequate. And using a leftover tube from a previous flare on a new rash risks treating something that is not eczema at all. If you have run out, that is a prescription request, not a borrowing problem.
What each Rx tier actually involves, monitoring, the specific fears (isotretinoin, steroid phobia, long-term antibiotics, biologics), tapering, what 'stronger' really buys.
Older systemic drugs that still work well. Ciclosporin acts fast but is limited to months by kidney and blood-pressure effects; methotrexate is slower and suits longer use.
Read the full answerHide the full answer
These predate the biologics and remain widely used, particularly where newer drugs are unavailable or unfunded. Ciclosporin is the fast option, often producing substantial improvement within two to six weeks, which makes it useful for breaking a severe flare — but it raises blood pressure and can affect kidney function, so it requires regular monitoring and is generally limited to courses of up to a year, often much less. Methotrexate is slower, taking two to three months for full effect, is taken once weekly with folic acid, requires blood monitoring for liver and blood counts, and is contraindicated in pregnancy for both partners around conception. Azathioprine is a third option, requiring an enzyme test before starting. All three are immunosuppressive, which affects vaccination and infection risk. They are not inferior consolation prizes — for many people they achieve control at a fraction of the cost of a biologic — but they demand more monitoring, and the choice between them and a targeted drug depends on speed, comorbidities, pregnancy plans and funding.
What are the newer non-steroid creams for eczema? #
Topical PDE-4 and JAK inhibitors — crisaborole and ruxolitinib cream — recommended in current guidelines for mild-to-moderate eczema, with no skin-thinning risk.
Read the full answerHide the full answer
The topical middle ground has expanded, which matters most for people who need long-term treatment on the face or folds. Crisaborole is a phosphodiesterase-4 inhibitor ointment for mild to moderate eczema; its main drawback is application-site stinging in a proportion of users. Ruxolitinib cream is a topical JAK inhibitor with strong efficacy data, restricted to short-term and non-continuous use in limited body areas, and carrying the class boxed warning despite minimal systemic absorption at recommended doses. Both appear as recommendations in the 2023 American guidelines alongside the older calcineurin inhibitors. The realistic constraints are availability and cost rather than effectiveness: neither is licensed or funded everywhere, and where they are, they typically require documented failure of cheaper options first. Their genuine value is as steroid-sparing agents — for maintenance on thin skin, for people with steroid phobia who will not use what they have been given, and for sites where accumulating steroid exposure is the thing you are trying to avoid.
What if I'm frightened of the steroid I've been given? #
Say so at the appointment. Undisclosed non-use looks identical to treatment failure, and it leads to escalation you may not need — there are non-steroid options.
Read the full answerHide the full answer
Steroid phobia is common enough to have been measured, and it is one of the main reasons prescribed eczema treatment does not get used. The problem is what it produces downstream: a clinician sees a patient whose eczema did not respond to a topical steroid and reasonably concludes that stronger treatment is required, when the actual situation is that the tube stayed in the cupboard. Saying it plainly changes the conversation entirely. Useful things to ask for: the specific potency and why it was chosen, how long you will be using it, what the realistic risks are at that dose and site, and what you should see if something is going wrong. Alternatives genuinely exist — topical calcineurin inhibitors carry no thinning risk and are well suited to face and folds, and newer non-steroidal topicals are available in some places. Two closing points: a defined plan with an end point is easier to accept than an open-ended one, and undertreated eczema has its own risks, which are not zero simply because they are less discussed.
Damp bandages or clothing applied over emollient, and sometimes diluted steroid, to cool the skin, block scratching and force absorption during a severe flare.
Read the full answerHide the full answer
Wet wrapping is a short-term rescue technique, used most often in children with severe flares and sometimes in adults. A layer of emollient, or a diluted topical steroid where prescribed, is applied, then covered with a damp layer of tubular bandage or cotton clothing and a dry layer over it, typically left for several hours or overnight. It works through three mechanisms at once: cooling, which relieves itch immediately; occlusion, which dramatically increases absorption of what is underneath; and a physical barrier that stops scratching during sleep. That increase in absorption is exactly why it should be set up with clinical guidance rather than improvised — wrapping over a potent steroid substantially raises systemic exposure, particularly in a small child. Used correctly it can break a flare that topical treatment alone was not settling, and families are usually taught the technique by a dermatology nurse. It is a short intervention of days rather than an ongoing routine, and it does not replace the maintenance plan underneath.
A self-given injection under the skin every two weeks after a loading dose, no routine blood tests, and topical treatment continuing alongside at a much reduced level.
Read the full answerHide the full answer
Practically, it is less of an undertaking than people expect. Treatment starts with a loading dose, then a subcutaneous injection every fortnight, given at home with a pre-filled pen or syringe after training — thigh or abdomen, rotating sites. Because it targets a specific inflammatory pathway rather than suppressing immunity broadly, it does not require the routine blood monitoring that ciclosporin or methotrexate do, which removes a considerable burden. Storage is refrigerated, with allowance to bring it to room temperature before injecting, and that matters for travel planning. Emollients continue permanently and topical anti-inflammatories usually continue at a much lower level rather than stopping, since most people are improved rather than perfectly clear. Reviews continue with the prescribing service, and treatment is generally ongoing rather than a fixed course — stopping usually leads to relapse over months. The things worth raising early are eye symptoms, which are the notable side effect, and any plans for pregnancy or vaccination.
Applying an anti-inflammatory to your usual trouble spots twice a week once they are clear, to stop flares starting — rather than waiting and treating each one.
Read the full answerHide the full answer
Reactive treatment means waiting for a flare and putting it out. Proactive treatment means keeping the fire from starting: after clearing a flare fully, you continue applying a medium-potency steroid or a calcineurin inhibitor to those same sites two days a week, indefinitely or for a defined period, while emollient continues everywhere daily. Guidelines recommend it, and the logic is that apparently normal-looking eczema-prone skin still carries subclinical inflammation, which is what relapses. Two things surprise people about it. It usually results in less total steroid used across a year than repeated rescue courses, because the flares being prevented would each have needed a fortnight of daily treatment. And it works best when the sites are chosen deliberately — the inner elbows, the neck, wherever yours always returns — rather than applied everywhere. Set it up as an explicit plan with your clinician, including which product, which days, and when to review. Vaguely continuing to use a steroid occasionally is not the same thing.
What strength of steroid am I on, and does it matter? #
It matters a great deal. Potency runs from mild to very potent, and the right one depends on the site, the thickness of the patch and your age — not on caution alone.
Read the full answerHide the full answer
Topical steroids are grouped by potency, and the classification differs between countries, which is a frequent source of confusion when reading advice online. Hydrocortisone 1% is mild. Preparations such as clobetasone butyrate sit in the moderate band, betamethasone valerate 0.1% in the potent band, and clobetasol propionate is very potent. The choice follows the site and the disease: mild on the face, eyelids and folds; moderate to potent on limbs and trunk; very potent reserved for thick, lichenified plaques and palms and soles, usually short-term. Matching matters in both directions. Too potent on thin skin causes the local effects people fear. Too weak on a thick patch does nothing except waste weeks and convince someone that steroids do not work for them, which is the far more common error. It is entirely reasonable to ask which band you have been given, why, how much to use, for how long, and what to do when it settles — and to write the answers down.
Usually none — eczema is a clinical diagnosis. Tests come in for specific questions: patch testing for contact allergy, swabs for infection, bloods before systemic drugs.
Read the full answerHide the full answer
Expect the diagnosis to be made by history and examination, which is standard and not a shortcut. Tests are ordered to answer particular questions rather than to confirm eczema. Patch testing identifies delayed contact allergy and is the most useful of them — indicated when eczema is not responding as expected, is confined to hands, eyelids or the face, or worsened after products or work exposure; it involves patches worn on the back for two days and readings across the following days. Skin-prick tests and specific IgE bloods look at immediate allergy and are used in children with suspected food triggers, with the important caveat that a positive result often reflects sensitisation rather than clinical allergy. Swabs are taken when infection is suspected. Blood tests come before and during systemic treatment, checking liver, kidney and blood counts, plus screening for tuberculosis and hepatitis. Biopsy is occasionally used when the diagnosis is genuinely uncertain, particularly in adult-onset disease that is not behaving as eczema should.
When properly used topical treatment has failed to control moderate-to-severe eczema — not after every option has been exhausted and not only when your skin looks dramatic.
Read the full answerHide the full answer
The threshold is lower than most people assume, and the qualifier that matters is properly used: adequate potency, adequate quantity, applied to the right areas, with emollient underneath. If that regimen is not holding, and eczema is affecting sleep, work, school or mood, escalation is appropriate. Phototherapy is often tried first where access allows. Beyond it sit conventional systemics such as ciclosporin and methotrexate, targeted biologics such as dupilumab and tralokinumab, and oral JAK inhibitors. Which comes first depends on speed needed, comorbidities, pregnancy plans, monitoring requirements and what your health system funds — most require documented failure of prior treatment. Two things people wait too long on. Severity is judged by impact as well as appearance, so lost sleep and lost days count and should be stated explicitly. And there is no merit in enduring years of inadequate topical treatment to prove you tried; that period costs skin thickening, repeated infection and, in children, growth and development. Ask directly what the criteria are and whether you meet them.
Because eczema rebounds hard when they stop, often worse than before, and repeated courses carry serious systemic risks for a condition needing years of control.
Read the full answerHide the full answer
Oral prednisolone clears eczema impressively and quickly, which is precisely the trap. Relapse on stopping is common and frequently more severe than the original flare, so the sequence turns into escalating courses to chase a receding baseline. Because eczema is a long-term condition, the cumulative exposure that implies brings bone thinning, diabetes risk, hypertension, weight gain, cataracts and adrenal suppression — a set of harms disproportionate to a skin condition with better options available. Guidelines therefore restrict systemic steroids to short bridging use in exceptional circumstances, such as controlling a catastrophic flare while a longer-term treatment is started. If you have been given them before and it worked wonderfully, that experience is real and also explains the reluctance. The productive question is not for another course but for what will hold control: proactive topical treatment, phototherapy, or a systemic agent designed for long-term use. Someone repeatedly needing oral steroids has, by definition, eczema that warrants one of those.
Whether to see a GP or a dermatologist, telederm, wait times, insurance and prior authorisation, generics, cost-saving that isn't dangerous, what to bring to the visit.
Should I see a GP, a dermatologist or an allergist? #
Start with the GP, who manages most eczema. Dermatology for treatment that isn't working; allergy services only when a specific allergy question exists.
Read the full answerHide the full answer
Most eczema is managed well in primary care, and a GP can prescribe emollients in proper quantities, the full range of topical steroid potencies and calcineurin inhibitors, and can treat infection. Dermatology is the referral that matters when topical treatment at adequate potency has failed, when the diagnosis is uncertain, when patch testing is needed, or when systemic treatment or phototherapy is being considered — those are specialist-initiated almost everywhere. Allergy services are more specific than people expect: appropriate for suspected immediate food allergy, particularly in a child with severe eczema, and for anaphylaxis history, but not a general route to explaining eczema, since eczema itself is not an allergy. Being clear about which question you want answered gets you to the right place faster. Two things speed a referral: documented treatment history with quantities and durations, and an account of impact including nights of lost sleep and days missed. If a referral is refused and your skin is not controlled, asking what threshold would change that is a fair question.
Ask for it by quantity. Proper use is 250–500 g a week for an adult, and prescriptions are often written for a fraction of that because nobody asked.
Read the full answerHide the full answer
Under-supply is one of the quiet causes of under-treatment. An adult treating widespread eczema properly gets through roughly 250 to 500 grams a week, and a child proportionally less but still far more than a small tube provides. If a prescription is issued as one 100 g tube a month, the arithmetic makes adequate use impossible, and the sensible response is to say exactly that: state how much you are using and ask for a quantity that matches, typically in 500 g pump dispensers. Where emollients are not prescribed or are excluded from coverage, buy the largest sizes of a basic ointment — plain white soft paraffin and similar products are inexpensive in bulk and perfectly effective. Two cautions worth knowing: paraffin-based emollients are flammable and can ignite on clothing and bedding near a naked flame, so smoking near them is dangerous; and communal tubs should be dispensed with a clean spoon or pump. Cost should reduce the elegance of your emollient, never the volume.
By documenting severity and failed treatment. Most systems require a validated severity score plus evidence that adequate topical therapy and often a systemic drug did not work.
Read the full answerHide the full answer
Approval turns on documentation rather than on how bad it feels, so the useful work is making the record match the reality. Funding bodies typically want a validated severity score above a threshold, a record of adequate topical treatment at appropriate potency and quantity, and in many systems failure or intolerance of at least one conventional systemic drug such as ciclosporin. Some also require a quality-of-life measure, which is where sleep loss, missed work and mental health legitimately count. Three things that help. Keep your own record of what was tried, at what dose and for how long, because reconstructing three years of treatment inside a fifteen-minute appointment produces a weak application. Attend the appointment during or shortly after a flare if you can, since scores are recorded on the day. And ask the specialist directly what the local criteria are and whether you meet them yet — if you do not, the answer will tell you exactly what is missing. Denials can be appealed, and appeals are frequently successful with better documentation.
Rarely. Validated testing has narrow indications, and the commercial tests sold direct to consumers — IgG panels, hair analysis, kinesiology — have no diagnostic value.
Read the full answerHide the full answer
Two categories get confused. Validated allergy testing — skin-prick tests, specific IgE blood tests and dermatological patch testing — is genuinely useful for specific questions, and patch testing in particular is worth pursuing when eczema is not responding, is on the hands or eyelids, or worsened after product exposure. That testing is best arranged through a clinician who will interpret it against your history, because a positive result without a matching clinical story usually means sensitisation rather than allergy, and acting on it leads to unnecessary avoidance. The second category is the direct-to-consumer market: food-intolerance IgG panels, hair mineral analysis, applied kinesiology, bioresonance. Allergy societies have repeatedly stated these have no diagnostic validity, and their practical output is a long list of foods to avoid, which is both expensive and harmful in children. If you want testing, the money is better spent on a consultation that decides whether testing is indicated at all than on a panel that will generate results nobody can interpret.
Are prescription emollients better than shop-bought ones? #
Not inherently. Many prescribed emollients are simple paraffin blends available to buy; the advantage of a prescription is quantity and cost, not superiority.
Read the full answerHide the full answer
The ingredients in most prescription emollients are unremarkable — paraffins, glycerin, occasionally urea or an antimicrobial — and equivalent or better formulations sit on pharmacy shelves. What a prescription genuinely provides is volume at low or no cost, which is the variable that determines outcomes, and in some systems this has narrowed as emollients have been removed from routine prescribing for milder cases. Two things worth knowing about the prescribed options. Some contain ingredients that suit certain situations and irritate others: urea helps thickened skin but stings broken skin, and antimicrobial-containing emollients are for specific circumstances rather than general use. And aqueous cream, historically dispensed as a leave-on moisturiser, contains sodium lauryl sulfate and has been shown to damage the barrier — it is a wash-off product at best, and many people were made worse by using it as instructed. Choose on ingredient list and greasiness rather than on where it came from, and pick whichever route gets the largest quantity into your house.
The treatment history with quantities, the number of nights sleep was lost, photographs of a bad day, and every product you put on your skin.
Read the full answerHide the full answer
Eczema appointments are short and the information that changes decisions is rarely volunteered without prompting. Bring four things. A treatment list: which creams, what potency, how much you actually get through in a week, and how long each was used — quantity is the single most revealing number, because inadequate volume explains most apparent failures. A sleep count: nights disturbed in the past fortnight, which is the impact measure clinicians act on and is far more useful than saying it has been bad. Photographs from a genuinely bad day, since appointments have an unhelpful habit of falling on good ones and colour changes are hard to describe. And a list of everything applied to your skin, including hand wash, laundry products, cosmetics and anything from a health shop, because contact allergy hides there. Add your questions in writing and ask two at the end: what should improve and by when, and what happens if it does not. Say plainly if you have not been using something as prescribed.
Ageing skin makes less lipid and holds less water, so eczema of later life is common. But new widespread eczema after sixty should be assessed rather than assumed.
Read the full answerHide the full answer
Skin changes substantially with age: lipid production falls, barrier repair slows, and surface pH rises, all of which make eczematous dryness far more likely — asteatotic eczema, with its characteristic crazy-paving pattern on the shins, is largely a condition of older skin and of winter heating. Medication contributes too, with diuretics, statins and others associated with dry skin. So new eczema at seventy is often simply eczema. What justifies a proper look rather than an assumption is the small number of serious mimics that present this way: cutaneous T-cell lymphoma can appear as patches resembling eczema for years before diagnosis, scabies is frequently missed in older adults and in care settings, and drug reactions and contact allergy are both common. Widespread redness, weight loss, lymph node swelling, or a rash that never responds properly to adequate treatment all warrant assessment and sometimes a biopsy. Treatment otherwise follows the same principles, with more emphasis on greasy emollients and gentler washing, and attention to the practicality of applying cream to a back.
What should school know about my child's eczema? #
Where the emollient is kept and that they may apply it, that eczema is not contagious, and that scratching and poor sleep affect concentration rather than behaviour.
Read the full answerHide the full answer
A short written note covering four points prevents most problems. First, emollient: where it is stored, that the child may use it during the day, and permission for staff to help a younger child — many schools require this in writing before anything can be applied. Second, that eczema is not contagious, which pre-empts exclusion from swimming, sports or shared activities that still occurs and is not medically justified. Third, triggers relevant to the setting: sand, paint, playdough, chlorinated pools, heat in classrooms, and specific soaps in the toilets, with a request that the child may wash with their own product. Fourth, and most overlooked, the impact of broken sleep on concentration and mood, so tiredness and irritability are read correctly rather than as behaviour. For older children, ask that they can leave the room to manage itching without drawing attention, and that PE kit rules allow long sleeves if they prefer. If bullying about visible skin arises, raise it early and formally rather than hoping it settles.
Often. Many improve, some worsen, and the distribution shifts towards hands, face and neck — while adherence typically collapses at exactly the wrong moment.
Read the full answerHide the full answer
Adolescence changes eczema in three ways at once. Biologically, hormonal shifts and increased sebum alter the picture, and while many teenagers improve, a subset flare significantly, with a recognised pattern of head, neck and hand involvement replacing the childhood flexural distribution. Practically, treatment ownership transfers from parent to teenager, and this is the point at which twice-daily emollient routines quietly stop — surveys consistently find adherence at its worst in this group. Socially, visible eczema on the face and hands lands during the years when appearance matters most, and greasy emollient before school is a genuine obstacle rather than a trivial complaint. What helps: simplifying the regimen to what will actually be done, choosing lighter daytime formulations even at some cost in efficacy, moving the heavy application to night, and handing over responsibility deliberately rather than by attrition. Two specifics worth checking: head-and-neck eczema that resists treatment may involve Malassezia and respond to an antifungal, and hand eczema often starts here with weekend jobs involving wet work.
Emollients and topical steroids are considered compatible, and mild-to-moderate potencies are first-line. Methotrexate and JAK inhibitors are not, and must be stopped beforehand.
Read the full answerHide the full answer
Eczema commonly changes in pregnancy — worsening for many, improving for some — and treatment is available throughout. Emollients carry no restriction and should increase rather than decrease. Topical corticosteroids are regarded as compatible: absorption through skin is small, and mild to moderate potencies are the usual choice, with caution around prolonged use of potent preparations over large areas, which has been associated with lower birth weight in observational work. Topical calcineurin inhibitors are also generally considered acceptable. Above that, positions diverge and the decision belongs with your obstetric and dermatology teams together: phototherapy is often regarded as a good option in pregnancy, ciclosporin is used where needed, dupilumab has accumulating reassuring data but is decided case by case, while methotrexate is absolutely contraindicated and must be stopped well in advance, and oral JAK inhibitors are avoided. Two practical points: undertreated severe eczema is not the safe option, since sleep loss, infection and stress carry their own risks; and plan changes before conception rather than after a positive test.
Yes — very little topical steroid reaches milk, so keep emollients going freely and simply wipe any treated area on the breast or nipple before feeding.
Read the full answerHide the full answer
Topical treatment during lactation is generally straightforward. The quantity of corticosteroid absorbed through skin and reaching breast milk is expected to be small, and typical use is not considered a risk to a breastfed baby; more caution applies to very potent preparations used over large areas for extended periods. The one specific instruction that matters is contact: anything applied to the breast or nipple should be wiped off before feeding so the infant's mouth and skin do not meet it directly. Nipple eczema is itself common in breastfeeding and worth treating rather than enduring, usually with a short course of a mild steroid ointment applied after feeds. Emollients need no restriction at all. For systemic treatment the picture is less uniform — some drugs are considered compatible with breastfeeding, others are not, and biologics are decided individually — so raise it specifically rather than assuming, particularly if you were on treatment through pregnancy. Postpartum flares are common, driven by sleep loss, hand-washing and hormonal change, and are worth pre-empting rather than absorbing.
Often for the worse. Falling oestrogen reduces skin lipids, collagen and water-holding capacity, so drier skin flares more easily and heals more slowly.
Read the full answerHide the full answer
Oestrogen supports sebum production, skin hydration, collagen and barrier repair, and its decline through perimenopause and after affects all four. In practice that means women with long-standing eczema frequently report it becoming drier, itchier and slower to settle, and some develop eczema for the first time in this period, most commonly on the hands, eyelids and lower legs. Night sweats and disturbed sleep compound it, since heat is a reliable itch trigger and sleep loss lowers the threshold for scratching. The adjustments are mostly about volume and richness: heavier ointments, more frequent application, cooler and shorter showers, and a lower threshold for treating a flare promptly rather than waiting it out. Two things worth raising with a clinician. Whether hormone replacement is appropriate for you is a broader decision, but skin dryness and itch are legitimate to mention among your symptoms. And generalised itching without a rash in this age group has other causes worth excluding — thyroid, liver, kidney and iron problems among them — so it should not simply be attributed to menopause.
Emollient generously and often, a non-soap wash, and a mild steroid on the active patches. Treating early and properly matters more than any product choice.
Read the full answerHide the full answer
Start with volume. Apply a fragrance-free emollient several times a day, always after bathing, in far larger quantities than feels necessary — this is the foundation and it continues whether the skin looks good or bad. Bathe daily in lukewarm water for five to ten minutes with a soap substitute, no bubble bath, and moisturise within minutes of lifting them out. For active patches, a mild topical steroid prescribed for a baby is appropriate and should be used properly rather than sparingly; the common pattern of applying a smear for two days and stopping leaves the eczema active. Keep nails short, dress in cotton, and keep the bedroom cool, since heat provokes itch. Two things to raise promptly with a clinician: sleep disruption for the baby or the household, which is the measure that justifies escalation, and any weeping, crusting, blistering or fever, which needs same-day assessment. And a specific point that surprises parents — do not delay introducing allergenic foods, because current guidance runs the opposite way.
Should I delay peanut and egg if my baby has eczema? #
No — the opposite. Early introduction reduces allergy risk substantially, and infants with severe eczema are the group where it matters most and needs medical guidance.
Read the full answerHide the full answer
This reversed within a decade and the old advice is still repeated widely, so it is worth stating plainly. The LEAP trial gave peanut to infants at high risk — those with severe eczema, egg allergy or both — from four to eleven months, and found around an eighty percent reduction in peanut allergy compared with avoidance. Guidance since has moved towards introducing peanut, egg and other common allergens from around four to six months rather than delaying them. The important qualifier for eczema families: infants with severe eczema or known egg allergy are precisely the group advised to have medical assessment before first introduction, which may include testing, rather than doing it unsupervised at home. Everyone else can generally introduce at home in age-appropriate forms — never whole nuts, which are a choking hazard. There is a mechanistic link back to the skin: allergen exposure through a damaged barrier is thought to promote sensitisation while oral exposure promotes tolerance, which is another argument for treating infant eczema well and early.
My toddler fights every application — what works? #
Make it routine, quick and non-negotiable rather than a negotiation. Warm the cream, apply during a distraction, and let them apply some themselves.
Read the full answerHide the full answer
Resistance is close to universal and it is a genuine reason treatment fails, so it deserves tactics rather than willpower. Attach applications to fixed points in the day — after the bath, before a story — so it is part of the sequence rather than an interruption to be argued about. Warm the emollient in your hands first, since cold cream on warm skin is unpleasant and provokes objection. Apply during something absorbing: a screen, a book, a song. Give a measure of control by letting them do a leg themselves or choose which limb comes first, and let a doll or teddy be creamed first. Apply in downward strokes rather than rubbing, which is more comfortable and reduces folliculitis. For nights, cotton sleepsuits with fold-over mittens and short nails limit the damage of scratching. And treat the itch properly — a child fighting cream is often a child whose skin hurts, and adequate anti-inflammatory treatment makes the emollient far more acceptable within days. Dermatology nurses are frequently the best source of practical help here.
Many improve substantially by adolescence, but a meaningful proportion continue into adulthood — and waiting rather than treating does not improve the odds.
Read the full answerHide the full answer
The honest answer has two halves. A good share of children with eczema see it improve markedly through childhood, and many are largely clear as adults, so the reassurance is not baseless. But cohort studies following children into later life find persistence higher than the folklore suggests, early severe eczema is more likely to continue, and some people with childhood eczema who appear to clear retain sensitive, easily irritated skin permanently, particularly on the hands. What the evidence does not support is treating it as a plan to be grown out of. Nothing about undertreating now improves the long-term trajectory, while the costs of waiting are concrete — lost sleep affecting growth and school, repeated infections, thickened skin, and a child who learns to scratch. There is also emerging interest in whether treating early and well influences the atopic march towards asthma and allergy, which if anything argues the other way. Treat what is in front of you, and let the long-term course be whatever it will be.
Pigmentary aftermath, keloid and scarring risk, how the condition presents differently, hair and scalp practices, laser and device safety by phototype, being dismissed or misdiagnosed.
Why am I left with dark or pale patches after a flare? #
Post-inflammatory pigment change — either darker or lighter than surrounding skin. It is not scarring, it is not bleaching from the steroid, and it does fade.
Read the full answerHide the full answer
Inflammation disturbs pigment production in both directions, and richly pigmented skin shows both more readily. Hyperpigmentation leaves brown or grey-brown marks where flares were; hypopigmentation leaves pale patches, which alarm people more because they are often assumed to be permanent damage or a consequence of steroid use. Neither is scarring, and neither means skin has been destroyed. A specific and very common pattern in children is pityriasis alba: pale, slightly scaly patches on the cheeks and upper arms, associated with eczema and dry skin, which resolves slowly over months. Timescales are the hard part. Pigment change routinely outlasts the eczema itself by many months, and there is no way to accelerate it dramatically. What does help: settling the inflammation quickly, since every new flare adds new pigment change; daily sun protection, because ultraviolet exposure deepens the contrast; and consistent emollient use. What does not help is treating pigment patches with steroid, which does nothing for them and adds risk.
Do my hair products affect scalp and hairline eczema? #
They can. Fragrance, preservatives and leave-in oils are common irritants, and infrequent washing to protect textured hair can let scalp inflammation and scale build.
Read the full answerHide the full answer
Scalp and hairline eczema sits at an awkward intersection of dermatology and hair practice, and generic advice frequently ignores the second. Products applied to the scalp — fragranced oils, gels, relaxers, dyes — are common irritants and sensitisers, and the residue migrates onto the forehead, neck and ears, which is why the rash often traces the hairline. At the same time, hair-care routines that involve washing every one to two weeks to protect textured hair mean any inflammation and scale sit undisturbed for longer, and medicated shampoos that require frequent use fit badly with that reality. Workable adaptations exist: applying a steroid scalp solution or oil directly to the scalp between washes rather than relying on shampoo alone, choosing fragrance-free products, patch-testing new hair products on the forearm first, and asking specifically for a treatment that suits your washing frequency rather than one assuming daily shampooing. Tight braids, weaves and heat also matter, since traction and heat provoke both itch and, separately, hair loss.
Could my eczema be under-treated because of how it looks? #
It is a documented risk. Severity tools weight redness heavily, redness reads poorly on deeper skin, and the result is systematically milder grading than the disease deserves.
Read the full answerHide the full answer
This is not a matter of perception. Research has repeatedly found that standard severity instruments, built and validated largely on lighter skin, underestimate severity in people with darker skin because they lean on erythema — and that Black patients with eczema experience higher severity and greater impact while being less likely to receive specialist care and systemic treatment. Access compounds it: dermatology referral rates, appointment availability and prescribing of newer agents all show disparities. What you can do about it is concrete. Bring measures that do not depend on colour — nights of disturbed sleep, an itch score, the number of body areas involved, days affected at work or school — and state them as numbers. Bring photographs from a bad day. Ask directly what would need to be true for escalation or referral, which converts a judgement into a criterion. And if you are told your eczema is mild while it is costing you sleep several nights a week, say that the two do not match. Second opinions are legitimate.
Do I need different moisturisers for deeper skin tones? #
Not different products, but often richer ones and larger quantities — and ashiness is a visible sign of dryness that pale skin simply doesn't show.
Read the full answerHide the full answer
There is no formulation that works differently by skin tone, so the ingredient answer is the same: fragrance-free, greasy, and used in volume. Two practical differences are worth naming. Dryness is visible as ashiness — a greyish, dulled surface — which is a genuinely useful early warning that pale skin does not display, and it should be read as a signal to apply more rather than as a cosmetic issue. And because ashiness is visible, many people are drawn to heavy oils and butters that look good immediately; some of these, shea and mineral oil among them, are fine, while fragranced body butters and coconut-scented products are common irritants. There is also evidence of greater transepidermal water loss in some studies of richly pigmented skin, which argues for more occlusive products rather than lighter ones. Choose an ointment or a rich cream, apply it while skin is damp, and treat the reappearance of ashiness as the cue to reapply rather than waiting for itch.
Probably follicular eczema, a variant far more common in deeply pigmented skin — small papules centred on follicles, very itchy, and often poorly responsive to standard steroids.
Read the full answerHide the full answer
Follicular accentuation is a recognised presentation of atopic dermatitis that is markedly more common in people with darker skin, and it looks unlike the textbook picture: instead of confluent patches, you see one-to-two millimetre bumps centred on hair follicles, often on the trunk and the outer surfaces of the limbs, giving the skin a permanently goose-pimpled texture. It itches considerably and, importantly, is frequently described as responding less well to topical corticosteroids than classical eczema, which means it is often labelled treatment-resistant when it is simply presenting differently. Two look-alikes need separating: keratosis pilaris, which is not itchy and does not flare, and folliculitis, which produces pustules and can follow greasy emollients rubbed in against the direction of hair growth. Raising the pattern explicitly is worth doing, because it changes management — clinicians may reach for a different vehicle, a calcineurin inhibitor, or escalate sooner rather than assuming non-adherence when a standard steroid underperforms.
Why doesn't my eczema look red like the pictures? #
In deeply pigmented skin, eczema often appears violet, grey or dark brown rather than red — which leads to severity being underestimated by patients and clinicians alike.
Read the full answerHide the full answer
Erythema is the feature most severity scales lean on, and it reads poorly against melanin-rich skin. Active eczema that would look bright red on pale skin commonly appears violaceous, greyish or darker brown, and reference images in textbooks and online overwhelmingly show the pale-skin version — so people compare their own skin to the pictures and conclude their eczema is mild. Clinicians using erythema-weighted scoring make the same error, and studies have specifically warned that relying on perceived redness leads to underdiagnosis and undertreatment of severe eczema in Black patients. Two consequences follow. Judge severity by what you can feel and count rather than by colour: warmth, thickening, how many areas are involved, how much sleep is lost, how much it itches. And if a clinician grades your eczema as mild while you are awake half the night, say that number out loud, because it is the measure least distorted by skin tone. Photographs in consistent lighting help, as does bringing images from a genuinely bad day.
Yes, and you should — the barrier to it is sweat and heat, both of which are manageable with timing, fabric and a shower afterwards.
Read the full answerHide the full answer
Exercise is worth protecting for reasons well beyond the skin, and eczema is not a reason to stop. What causes the trouble is heat and sweat: rising skin temperature triggers itch directly, and sweat left to dry contains salts and urea that irritate broken skin. Manageable specifics — exercise in a cool environment or at a cooler time of day where possible, wear loose breathable layers rather than tight synthetic ones, shower promptly afterwards rather than sitting in damp kit, and apply emollient immediately after showering. For flexural eczema in the elbows and knees, friction adds to the problem, so a barrier ointment beforehand helps. Swimming is often the best-tolerated option because it removes the heat problem entirely. Two extras: chlorinated pools and gym equipment need rinsing off, and eczema on the hands makes gripping weights or bars uncomfortable, where gloves or taping helps. If exercise reliably causes a raised itchy rash with wheals rather than an eczema flare, that is cholinergic urticaria and a different problem.
Yes. Chlorine dries skin and stings broken patches, but the fix is rinsing and re-moisturising immediately afterwards rather than giving up swimming.
Read the full answerHide the full answer
Swimming is worth protecting: it is one of the few exercises that does not involve overheating and sweating against the skin, and children with eczema are still occasionally excluded from lessons on the mistaken belief that the condition is contagious. Chlorinated water does dry the skin and can sting open areas, and heavily chlorinated pools are worse. The routine that solves most of it: apply a thick layer of emollient or an ointment before swimming as a partial barrier, rinse thoroughly in fresh water immediately afterwards rather than letting pool water dry on the skin, then apply emollient again while damp. Interestingly, dilute chlorine is the same principle as a bleach bath, which is why some people find pools neutral or even helpful. Sea water is variable — the salt stings broken skin but many find it improves their eczema overall. Two extras: shower gels in changing rooms are usually fragranced, so take your own, and avoid swimming with actively infected or weeping skin.
Say it plainly and early rather than managing it invisibly — greasy emollient, night scratching and shared beds are practical things a partner can accommodate once told.
Read the full answerHide the full answer
The practical friction is real and rarely discussed: ointment on bedding, scratching that wakes someone else, avoiding intimacy during a bad flare, and the exhaustion of trying to conceal skin. Concealment is the part that costs most, because it means managing the condition worse — skipping the greasy night application, avoiding the shower routine, staying dressed. Most partners respond better to a short explanation than to unexplained avoidance: what it is, that it is not contagious, that it flares and settles, and what actually helps. Specifics worth negotiating: old sheets or a towel over the bed on ointment nights, a cooler bedroom, and separate blankets if heat is a trigger. Intimacy during a flare is a matter of preference, and lubricants and condoms are worth choosing fragrance-free, since both can irritate. Genital eczema exists, is common, is often too embarrassing to raise, and is very treatable — a mild steroid ointment usually settles it, and thrush is frequently misdiagnosed in its place.
Cotton liners under waterproof gloves, emollient at every sink, and a written record — occupational hand eczema is often reportable and sometimes preventable by changing tasks.
Read the full answerHide the full answer
Hand eczema is the most common occupational skin disease, and it concentrates in wet work: healthcare, catering, cleaning, hairdressing, childcare and construction. Gloves are the main defence and are frequently used wrongly. Waterproof gloves worn for long periods trap sweat, which macerates skin and makes things worse, so wear a thin cotton liner underneath, keep glove time as short as the task allows, and take them off between tasks. Latex gloves are a sensitisation risk; nitrile is generally preferred. Then the routine around the sink: a soap substitute rather than institutional hand soap where possible, lukewarm water, thorough drying including between the fingers, and emollient after every wash — which means a tub at every sink you use, not one in a locker. Alcohol gel actually stings less than repeated washing on damaged skin, contrary to expectation. Two structural points: report it to occupational health, since hand eczema is a recognised occupational disease with obligations attached, and get patch tested, because occupational allergens are frequently identifiable and avoidable.
Cool the room, apply emollient generously before bed, cover the worst areas, and treat the inflammation properly — night itch is a severity signal, not a habit.
Read the full answerHide the full answer
Itch genuinely worsens at night: skin temperature rises, cortisol falls, and there is nothing to distract from it. The measures that help are unglamorous and additive. Keep the bedroom cool, around sixteen to eighteen degrees, with light bedding, since overheating is the single most reliable trigger. Apply a generous layer of emollient or ointment shortly before bed. Cover the worst areas — cotton pyjamas, mittens for children, a damp wrap during a severe flare — to blunt unconscious scratching. Keep nails short and filed. A cool damp cloth held on a burning area interrupts the itch signal for long enough to fall asleep. Sedating antihistamines can help occasionally, for sleep rather than for itch, and are not a long-term plan. Above all, treat sleep loss as the escalation signal it is: several disturbed nights a week is the outcome measure clinicians act on, and it justifies stronger treatment rather than better coping. Report it as a number of nights, not as being tired.
Substitute rather than resist. Habit-reversal techniques, cold instead of nails, short nails and covered skin work better than willpower, which reliably fails.
Read the full answerHide the full answer
Much scratching is automatic and unconscious, which is why deciding to stop does not work and why feeling guilty about it is pointless. Habit-reversal training has a real evidence base in eczema and is straightforward in principle: notice the trigger, then perform a competing action — pressing or pinching the skin, clenching a fist, applying cold — instead of scratching, consistently, until the substitution becomes the automatic response. Counting scratching episodes for a few days first is oddly effective on its own, because awareness is most of the battle. Alongside it: keep nails short and smooth, apply something cold rather than nails to an itchy patch, keep emollient within reach so the reflex reaches for a tub instead, and cover the worst areas at night. What matters more than all of it is that itch is a symptom of active inflammation — properly treated eczema itches far less, and someone scratching relentlessly despite good technique usually needs stronger treatment rather than better discipline. Persistent compulsive scratching with distress warrants psychological support alongside skin treatment.
Cold air holds less moisture, indoor heating dries it further, and hot showers strip lipids — the combination is a barrier under sustained attack.
Read the full answerHide the full answer
Winter worsening is the commonest seasonal pattern and has several overlapping causes: low outdoor humidity, central heating producing very dry indoor air, the temperature swings between the two, hot showers and baths taken for comfort, and heavier or woollen clothing against the skin. The response is to change the supporting routine before the season rather than after the flare. Move to a greasier emollient and increase the frequency, drop shower temperature and duration, add a humidifier if indoor air is very dry, and switch to smooth layers rather than one thick woollen one. Have your anti-inflammatory treatment in the house before you need it, because a flare treated on day one is a fortnight of work and one treated on day ten is a month. Summer is not automatically easier — heat, sweat and sun cream cause their own problems, and some people follow the opposite pattern entirely. Tracking your own seasonal shape over a year is more useful than assuming the standard one applies to you.
Daily is fine and often helpful — provided it is short, lukewarm, soap-free, and followed immediately by emollient. It is the drying-out afterwards that causes harm.
Read the full answerHide the full answer
Advice on this has swung both ways and the current position is that bathing frequency matters less than what surrounds it. A daily bath or shower of five to ten minutes in lukewarm water removes crust, scale, sweat and bacteria and hydrates the outer layer, and following it within a few minutes with emollient locks that water in. Skipping the emollient step is what turns bathing into a drying event, and it is why the same bath helps one person and harms another. Practical specifics: lukewarm rather than hot, since heat provokes itch and strips lipids; a soap substitute rather than soap or bubble bath; pat dry rather than rub; and no washcloths or loofahs on eczematous skin. Where a longer soak has a role is in soaking off thick scale or crust before treatment. Twice-daily bathing during a severe flare is sometimes recommended for the same reason. The one thing worth avoiding entirely is a long hot shower that feels wonderful on itchy skin and reliably makes the next few hours worse.
What should I plan before travelling with eczema? #
Take more than you need in hand luggage, expect climate and water changes to flare it, and carry a written prescription list for security and pharmacies abroad.
Read the full answerHide the full answer
Travel disrupts eczema through several channels at once: cabin air is extremely dry, water hardness and climate change abruptly at the destination, hotel toiletries are fragranced, bedding and detergents are unfamiliar, and routines slip. Plan around each. Carry emollient in hand luggage and apply it during the flight; take enough for the whole trip plus a margin, since finding your product abroad is unreliable. Keep prescription medication in original labelled packaging, and take a printed list of drug names — generic names, not brand names, which differ by country — for security and for any pharmacy you need. If you are on a refrigerated biologic, arrange a cool bag and check airline rules in advance. At the destination, take your own wash product, request extra towels rather than using scented laundry products, and expect a settling-in period. Hot climates bring sweat and sun; cold ones bring dry air. Two useful extras: a covering letter from your clinician if you carry needles, and travel insurance that declares the condition.
Smooth, loose and breathable — cotton and silk over wool. Wool next to skin is a well-documented irritant, and overheating provokes itch more than fabric type does.
Read the full answerHide the full answer
Two properties matter: how the fabric feels against skin, and how well it lets heat escape. Coarse wool is the classic irritant, causing itch mechanically through fibre diameter rather than through allergy, and it is worth avoiding next to skin even in people who tolerate it elsewhere — though fine merino has performed better than expected in some trials. Cotton and silk are the traditional recommendations and remain sensible. Synthetics are more mixed: they irritate less than wool but trap heat and sweat, which is the bigger problem during exercise or in a warm bed. Beyond fabric, the details that people notice: seams, labels and elasticated cuffs cause localised patches, so seamless garments or clothes worn inside out help; loose beats tight; and layering allows heat to be shed quickly, which matters because overheating is one of the most reliable itch triggers there is. Specialist silk or silver-impregnated garments are marketed for eczema, and a large trial in children found no meaningful benefit over standard clothing.
Somewhat. Fabric softener and heavily fragranced detergent are the parts worth removing; residue matters more than the brand, so an extra rinse helps.
Read the full answerHide the full answer
Detergent is a smaller factor than most people assume and a real one for some. The components most likely to cause trouble are fragrance and, in particular, fabric conditioner, which is designed to deposit a residue on fabric and sits against skin all day — dropping it is the single change most worth making. Biological detergents containing enzymes have been studied and largely exonerated as a cause of eczema, despite their reputation, though people who react are entitled to avoid them. Beyond product choice, the practical variable is how much detergent remains in the fabric: using less than the recommended dose, not overloading the machine, and running an extra rinse cycle removes more residue than switching brands does. Wash new clothes before wearing them, since finishing chemicals and dyes can irritate. And keep expectations proportionate — if changing detergent makes no difference over a month, it was not the driver, and the search is better redirected towards emollient quantity than towards a fourth product.
Yes, permanently. The barrier defect does not resolve when the visible eczema does, and stopping emollient during good periods is the commonest cause of the next flare.
Read the full answerHide the full answer
This is the part of the plan that people quietly abandon, and it is the part that determines how often eczema returns. The underlying barrier is structurally impaired whether or not there is a visible patch: it loses water faster and admits irritants more readily even in apparently normal skin. Emollient substitutes for that defect, and trials show consistent use reducing flare frequency and reducing how much anti-inflammatory treatment is needed over a year. Stopping during a good spell removes the protection precisely when there is nothing else in place. The realistic version of forever is to find a level you will genuinely sustain — perhaps twice daily rather than four times, a formulation you do not mind, tubs kept where you will encounter them — since a reduced routine maintained beats a perfect one abandoned. Two supporting habits: reorder before you run out, and keep going through good months and holidays, which are exactly when the tub gets left behind and the next flare is seeded.
It can go into long remission, and many people are effectively clear for years. What does not go away is the underlying tendency, which is why maintenance continues.
Read the full answerHide the full answer
Remission is realistic and common; cure, in the sense of the underlying barrier and immune tendency disappearing, is not something current treatment offers. Many people experience long periods with no visible eczema, particularly with consistent emollient use and proactive treatment of their known sites, and childhood eczema frequently becomes far less prominent in adult life. What tends to persist even then is sensitivity: skin that reacts to soaps, wet work and irritants more readily than average, and that flares under the right combination of triggers years later. Framing it as a condition that is controlled rather than cured is not pessimism — it is what prevents the cycle of stopping everything during a good spell and being surprised six weeks later. Systemic treatments have shifted expectations considerably: sustained near-clear skin is now an achievable target for severe disease rather than an aspiration. But those are ongoing treatments, and stopping them generally means gradual relapse rather than a permanent cure.
My eczema came back after years clear — why now? #
Usually a change in exposure or circumstance rather than the condition returning from nowhere: a job, a house, a medication, a stressful period, or ageing skin.
Read the full answerHide the full answer
Eczema that has been quiet for years reappears often enough to be unremarkable, and the useful work is looking at what changed in the preceding months. Occupational exposure is the biggest single category in adults, particularly anything involving wet work, and it frequently starts on the hands. Moving house brings different water hardness, heating and humidity. New medications, pregnancy, menopause and ageing skin all shift the baseline. Prolonged stress and disrupted sleep lower the threshold. And contact allergy can develop at any age, so a rash appearing after a new hobby, product or piece of jewellery deserves patch testing rather than assumption. Two caveats keep the answer honest. Some recurrences have no identifiable trigger and that is not a failure of investigation. And an adult rash that behaves like eczema but does not respond to adequate treatment should be looked at properly rather than escalated indefinitely, since several conditions imitate eczema in adults. Treatment principles are otherwise unchanged — the same emollient volume, the same early intervention.
Often yes. Treat at the first itch or roughness rather than waiting for visible redness — a flare caught on day one takes days to settle instead of weeks.
Read the full answerHide the full answer
Most people wait until eczema looks bad before treating it, which cedes the advantage entirely. The early signals are tactile rather than visual: a patch that feels rough, a return of itch in an old site, skin that feels tight or prickly. Acting then — increasing emollient immediately and starting the anti-inflammatory the same day — routinely settles things within days, where the same flare left for a week takes two to three weeks and more potent treatment. Building that into a plan makes it happen. Keep treatment in the house rather than needing a prescription first, agree with your clinician what you may start on your own initiative and when, and know your personal triggers well enough to pre-empt predictable ones: a cold snap, a stressful fortnight, a holiday, a change of water. Proactive twice-weekly treatment on the sites that always relapse is the systematic version of the same idea. Two things that undermine it are running out of emollient and hesitating over whether it is bad enough yet.
What should a written flare plan actually contain? #
Which product, how much, where, for how long, what to do if it isn't better in a week, and who to contact — agreed in advance, kept where you can find it.
Read the full answerHide the full answer
A flare plan converts a vague instruction into something usable at nine on a Sunday evening. Six components make it work. The daily baseline: which emollient, how much, how often. The step-up: which anti-inflammatory, applied to which sites, how many times a day, and for how long. The step-down: what to do once it settles, including whether you move to twice-weekly proactive treatment. The review point: what should have happened by day seven, and what to do if it has not. The infection triggers: weeping, golden crusting, painful skin, fever — and whether you have anything at home for that. And contacts: who to call and out-of-hours arrangements. Ask for it in writing, because verbal instructions decay within days and are impossible to follow under pressure. Keep it with the creams rather than in a drawer. For a child, a copy goes to anyone caring for them. Two additions worth requesting: how much you should be getting through in a week, and when the next review is.
Why does it always come back in the same places? #
Those sites carry residual subclinical inflammation even when they look normal, and they are usually where skin flexes, rubs or gets wet most.
Read the full answerHide the full answer
Skin that has been eczematous retains immune memory: resident T cells persist in previously affected areas, and low-grade inflammation continues after the visible signs settle, which is why relapse maps so precisely onto old sites rather than appearing randomly. Mechanics reinforce it — the flexures crease and rub constantly, hands are washed and exposed, the neck and eyelids are thin and get products applied to them. Two things follow practically. This is the specific situation proactive treatment was designed for: applying an anti-inflammatory to those known sites twice weekly while they look clear prevents the relapse rather than treating it, which is guideline-recommended and uses less medication over a year. And repeatedly affected areas thicken into lichenified patches that itch more than fresh eczema and need more potent treatment for longer, so leaving them to cycle makes each round harder. If one site alone keeps returning while everything else stays controlled, that is worth a second look for a local cause — a contact allergen, friction, or a different diagnosis.
Distress out of proportion to severity, picking and compulsion, being told it's vanity, work and school and dating, when to get mental-health support alongside skin treatment.
Caring for my child's eczema is exhausting — is that normal? #
Entirely. Parental sleep loss and stress in moderate-to-severe childhood eczema are well documented, and they are a reason to escalate treatment rather than to cope harder.
Read the full answerHide the full answer
The burden on families is measurable and routinely omitted from the conversation. Parents of children with moderate-to-severe eczema lose substantial sleep over years, and studies find raised rates of anxiety, depression and relationship strain among them. On top of that sits the daily labour: applications several times a day, laundry, holding a distressed child still, appointments, and the guilt that comes from being blamed by relatives and occasionally by professionals. None of that is a sign of coping badly. Two things are worth doing rather than enduring. Say it explicitly at appointments — the impact on the household is a legitimate factor in deciding whether to escalate, and it is invisible unless stated in concrete terms like nights of lost sleep per week. And share the load where possible, including with a partner, a dermatology nurse who can teach technique, and patient organisations that run family support. If your own mood has been low for weeks, that deserves its own attention rather than being deferred until the child's skin improves.
Treat it as a real symptom rather than something to endure quietly — the psychological load of chronic itch is comparable to chronic pain, and it responds to structured techniques.
Read the full answerHide the full answer
Chronic itch behaves like chronic pain: it occupies attention, disrupts sleep, and gets steadily harder to tolerate as reserves deplete. It is also invisible, which means people carry it while looking fine, and are often told it cannot be that bad. Naming that is the first useful step. Beyond it, techniques with genuine evidence exist. Habit-reversal training reduces scratching by substituting a competing action. Cognitive and relaxation approaches reduce the distress that amplifies the itch signal. Distraction is not trivial advice — occupying the hands during high-risk periods works. Cold applied to an itchy area interrupts the signal for long enough to break the loop. Structured psychological support delivered alongside dermatological treatment improves skin outcomes, not merely mood. And the most direct lever remains the medical one: itch is generated by active inflammation, so a treatment plan that leaves you itching relentlessly is not yet adequate, however well you cope with it. Coping better should not be the substitute for treating harder.
One short factual sentence, repeated without elaboration: it's eczema, it's a long-term skin condition, and it isn't contagious. Then change the subject.
Read the full answerHide the full answer
Being asked about visible skin is constant, and the exhausting part is not the question but the advice that follows it. A prepared line ends the exchange faster than an explanation invites debate: naming the condition, noting it is long-term and managed, and confirming it is not catching covers everything a stranger or colleague needs. Elaborating invites suggestions about diet, stress and creams that a well-meaning person has read about, and there is no obligation to receive them. Decide in advance who gets more — a partner or close friend reasonably wants to understand the routine, the flares and the bad weeks, and telling them makes the condition easier to live with rather than harder. For children, giving them their own sentence to use is genuinely protective, because being asked repeatedly without an answer ready is where the self-consciousness sets in. Where it crosses into staring, comments about hygiene, or exclusion from activities, that is not curiosity and does not need managing politely — for a child at school, it is a matter to raise formally.
Yes. Eczema is strongly associated with depression, anxiety and sleep loss, and the association tracks itch and sleep far more than how the skin looks.
Read the full answerHide the full answer
The psychological burden of eczema is well documented and consistently underestimated by everyone except the people carrying it. Studies find substantially raised rates of depression and anxiety in adults with atopic dermatitis, and the strongest drivers are chronic itch and chronic sleep deprivation — which is important, because it means the distress is a physiological consequence of the disease rather than a failure of resilience. Broken sleep alone degrades mood, concentration and pain tolerance within days. Add visible skin on the face and hands, the effort of a daily routine, and years of being told to try a different cream, and low mood is a rational response rather than a disproportionate one. Two things follow. Distress is a legitimate reason to escalate treatment, and it should be said out loud at appointments, because clinicians act on impact and cannot see it. And treating the eczema properly frequently lifts mood substantially — the causal arrow runs mostly from skin and sleep towards mood, which means the skin plan is also part of the mental health plan.
When should I get mental health support alongside treatment? #
When mood, anxiety or avoidance has persisted for weeks independent of how your skin is doing, or when you are avoiding work, school or people because of it.
Read the full answerHide the full answer
There is a useful distinction between feeling low during a bad flare, which is expected and usually lifts as the skin settles, and a mood problem that has taken on its own momentum. Signals for the second: low mood or anxiety persisting for weeks including through better skin periods, withdrawing from work, education or social contact, avoiding situations that involve being seen, compulsive scratching or picking that continues when skin is calm, or sleep problems that persist once the itch is controlled. Any thoughts of self-harm warrant help promptly rather than at the next dermatology appointment. What helps is not vague. Psychological interventions delivered alongside skin treatment — cognitive approaches, habit reversal, relaxation training — improve both mood and eczema severity in trials. Some dermatology services have psychological support attached and it is reasonable to ask. Two practical points: raise it with whoever you see about your skin, since they can refer and will factor it into treatment decisions, and do not wait for clear skin as the precondition for addressing it.
It may not be eczema. Cutaneous T-cell lymphoma, scabies, drug reactions and contact allergy all imitate it, and a biopsy is reasonable when treatment consistently fails.
Read the full answerHide the full answer
New widespread eczema in an adult that resists adequate treatment deserves reassessment rather than escalation on the same assumption. Several conditions imitate it. Cutaneous T-cell lymphoma, in its early mycosis fungoides stage, can appear as scaly patches indistinguishable from eczema for years, often on sun-protected areas such as the buttocks and thighs, and it is diagnosed by biopsy, sometimes needing several over time. Scabies is frequently missed, itches ferociously at night, involves finger webs, wrists, waist and genitals, and affects household contacts. Drug reactions can produce a diffuse eczematous rash weeks to months after starting a medication. Contact allergy is common and identifiable by patch testing. Rarer possibilities include internal disease presenting with itch. The practical signals that argue for a second look: onset after fifty with no prior history, patches that never fully clear despite correct treatment, lymph node swelling, weight loss, or a rash that does not fit the usual distribution. Asking directly about a biopsy is entirely reasonable at that point.
What is eczema herpeticum and how would I spot it? #
A herpes virus infection spreading across eczematous skin — crops of painful punched-out sores or blisters, often with fever. It is a medical emergency needing same-day care.
Read the full answerHide the full answer
Eczema herpeticum is dissemination of herpes simplex virus across skin whose barrier is already broken, and it is the complication of eczema that most needs recognising on sight. The pattern is distinctive: clusters of small monomorphic blisters that break down into punched-out, uniformly round erosions, typically appearing over a few days on areas of existing eczema, most often the face, neck and upper trunk. It is painful rather than itchy — pain in eczema is always a signal — and is frequently accompanied by fever, malaise and swollen glands. It can spread rapidly, and delayed treatment carries risks including secondary bacterial infection, eye involvement and, rarely, death. What to do is unambiguous: seek medical care the same day, through urgent care or an emergency department out of hours, and say the words eczema herpeticum, because it is missed when described as a worsening flare. Treatment is oral or intravenous aciclovir, and steroid creams are usually paused. Anything near the eye needs ophthalmology involvement urgently.
Weeping, golden-yellow crusting, pain, sudden worsening or a flare that stops responding to treatment — with fever or spreading redness making it urgent.
Read the full answerHide the full answer
Eczematous skin is colonised by staphylococcus far more heavily than normal skin, and secondary bacterial infection is common enough to be considered whenever a flare behaves unusually. The signs worth knowing: weeping or oozing, golden or honey-coloured crusting, skin that is painful rather than only itchy, a sudden deterioration over a day or two, small pustules, an unpleasant smell, or a flare that has stopped responding to treatment that previously worked. Fever, feeling unwell, spreading redness beyond the eczema, or red streaks tracking away from an area all raise the urgency to same-day. Treatment usually means an antibiotic, oral or topical depending on extent, often alongside continuing the eczema treatment rather than stopping it, since uncontrolled inflammation keeps the barrier open. Swabs may be taken. Two distinctions matter: painful blisters in crops suggest a viral rather than bacterial infection and are more urgent, and recurrent infections are a reason to review the underlying control rather than to keep prescribing antibiotics.
When most of the skin is red and shedding. Erythroderma disrupts temperature control and fluid balance and needs hospital assessment the same day.
Read the full answerHide the full answer
Erythroderma means inflammation of the great majority of the skin surface, typically with widespread redness and continuous scaling or shedding, and it can complicate severe eczema as well as psoriasis and drug reactions. It is a medical emergency because the skin's systemic functions fail together: heat is lost through dilated vessels causing shivering and unstable temperature, fluid and protein are lost through the surface, the heart works harder, and the risk of systemic infection rises. Warning features alongside the redness include feeling cold and shivering despite looking flushed, swelling of the legs, rapid heartbeat, feeling profoundly unwell, and dehydration. This is an emergency-department presentation rather than a next-available-appointment one, and treatment usually involves admission for fluid and temperature management, intensive topical treatment and identifying the trigger — which is sometimes a drug, and sometimes the abrupt withdrawal of systemic steroids. Anyone with extensive eczema should know this exists, because the transition from a bad flare to erythroderma can be gradual enough to be missed at home.
When does a baby's eczema need urgent attention? #
Same-day for blistering, punched-out sores, fever, spreading redness or a baby who is feeding poorly or unusually drowsy — sooner rather than later for anything you're unsure of.
Read the full answerHide the full answer
Infants have a large skin surface relative to their size, absorb more of what is applied, and become unwell faster, so the threshold for being seen is deliberately lower than for an adult. Urgent, same-day features: any crop of blisters or punched-out sores, which raises the possibility of eczema herpeticum; fever alongside a worsening rash; weeping and golden crusting suggesting bacterial infection; redness spreading rapidly; and any change in the baby themselves — poor feeding, unusual drowsiness, inconsolable distress. Prompt but not emergency: eczema that is not settling with prescribed treatment within a week or two, sleep disruption for the baby, or a rash appearing in the first weeks of life. Two extra points for parents. Eczema in a young infant that is severe and resistant is a reason for specialist input rather than repeated short courses of mild cream. And any suspicion of scabies, which itches intensely and involves palms and soles, needs treating for the whole household. Trust the escalation instinct rather than waiting for certainty.
When most of your skin is red and shedding with shivering, fever or feeling unwell — erythrodermic psoriasis is a medical emergency needing same-day care.
Read the full answerHide the full answer
Erythrodermic psoriasis involves the great majority of the skin surface in redness and continuous shedding, and it is dangerous because the skin's systemic functions fail together: heat is lost through dilated vessels causing shivering and unstable temperature, fluid and protein are lost through the surface, the heart works harder, and the risk of systemic infection rises sharply. Warning features alongside the redness: feeling cold and shivering despite looking flushed, fever, rapid heartbeat, swelling of the legs, dehydration, and feeling profoundly unwell. Common precipitants include abrupt withdrawal of oral corticosteroids, severe infection, and occasionally a drug reaction — which is one of the main reasons oral steroids are avoided in psoriasis. This is an emergency-department presentation rather than a next-available-appointment one, and treatment usually involves admission for fluid and temperature management, intensive topical care and a rapid-acting systemic agent such as ciclosporin or a biologic. Anyone with extensive psoriasis should know this exists, because the transition from a bad flare can be gradual enough to miss at home.
What a clinic can do that a tube cannot, what each procedure actually feels like and costs, how many sessions, downtime, who should not have it, and which devices are marketing.
What does patch testing involve, and does it hurt? #
Patches taped to your back for two days, then two or three readings across the following days. Not painful — the awkward part is not washing or sweating for 48 hours.
Read the full answerHide the full answer
Patch testing identifies delayed contact allergy, and it is the single most useful investigation in eczema that is not behaving as expected. Small chambers containing standardised allergens are taped to the upper back and left in place for forty-eight hours. They are then removed and the skin is read, with a second reading at around day four and sometimes a further one later, because reactions develop over days rather than minutes. It is not painful; the practical difficulty is the restriction — no showering, swimming or heavy exercise while the patches are on, keeping the back dry, and attending three appointments in one week. Some people get itching under a positive patch, which is the point. Preparation matters: no topical steroid on the back for a week or two beforehand, no sunbathing, and oral steroids and immunosuppressants can suppress results, so declare everything you take. Bring your own products, since testing your actual cosmetics, gloves and work materials alongside the standard series is often what finds the answer.
Are there specialist eczema clinics or day treatment units? #
Yes, and they are underused. Nurse-led education and day treatment produce large improvements largely by teaching technique and quantity properly.
Read the full answerHide the full answer
Many dermatology services run nurse-led eczema clinics, education sessions or day treatment units, and their results are better than the modest description suggests — largely because they spend an hour on what a standard appointment covers in two minutes. What happens there: demonstration of how much emollient and topical steroid to apply and where, wet wrapping taught hands-on, a written flare plan, and time to ask the questions that get abandoned when a consultation overruns. For families with a child whose eczema is not controlled, this is frequently more valuable than another prescription, because the commonest failure is technique and quantity rather than product choice. Day treatment units, where they exist, provide intensive treatment over several days for severe disease as an alternative to admission. Access varies enormously by region and is worth asking about explicitly, since referral is often not offered by default. Patient organisations also run practical education, and their advice lines are staffed by people who know what a real week looks like.
Barely. Targeted excimer light has a niche role for stubborn localised patches; general cosmetic lasers have no place and can provoke flares.
Read the full answerHide the full answer
Eczema is an immune and barrier condition rather than a structural one, so the device categories that transform acne scarring or pigmentation have little to offer. The one genuine exception is targeted phototherapy: the excimer laser or lamp delivers narrowband ultraviolet light to a small area at higher intensity than a whole-body cabinet, which suits isolated resistant patches — a stubborn area of hand eczema, for instance — while sparing unaffected skin. It is limited by availability and cost, and it is phototherapy rather than a laser treatment in the cosmetic sense. Everything else marketed at this condition deserves scepticism. Ablative and resurfacing lasers injure the barrier, which is the last thing eczematous skin needs, and any procedure risks the Koebner phenomenon, where trauma provokes new disease at the site. If you want a cosmetic laser procedure for an unrelated reason, it is usually done on clear, well-controlled skin with a test patch, and worth discussing with your dermatologist rather than only with the clinic selling it.
Do saunas, salt rooms or cryotherapy help eczema? #
None has meaningful evidence. Salt water and sunshine help some people, which is where the idea comes from, but the commercial versions are largely unstudied.
Read the full answerHide the full answer
Balneotherapy — bathing in mineral-rich water, classically at the Dead Sea, usually combined with sunlight — has some supportive literature, and many people genuinely improve on that kind of holiday. What is difficult is separating the water from the sun, the humidity, the rest and the absence of work stress. The commercial derivatives are weaker propositions. Salt rooms and halotherapy have essentially no trial evidence in eczema. Whole-body cryotherapy is unstudied for it and involves extreme cold, which is a poor idea for skin whose barrier is already compromised. Saunas cut both ways: heat provokes itch during and immediately after, though some people report benefit from the sweating and the humidity, and the safest approach is a cool rinse and emollient straight afterwards. Two general notes. Anything expensive marketed as an eczema cure warrants the same scepticism you would give a cream making that claim. And a warm humid holiday improving your skin is real information about your triggers, even if the mechanism is not the one being sold.
Standing in a lit cabinet for seconds to minutes, two or three times a week for eight to twelve weeks. Effective and safe; the obstacle is attendance, not tolerance.
Read the full answerHide the full answer
Narrowband UVB is delivered in a cabinet lined with lamps, and the exposure itself is short — starting at seconds and building over the course, usually under ten minutes even at higher doses. Goggles protect the eyes, genitals are covered, and the dose is calculated from your skin type and increased gradually. Sessions run two or three times a week for around eight to twelve weeks, and improvement typically builds from about week three or four. Side effects during a course are mostly mild: redness like light sunburn if the dose advances too quickly, dryness, and occasionally itch early on, alongside a small risk of provoking cold sores. Emollients continue throughout, though some are applied only after treatment because they can block the light. The genuine barrier is logistical rather than medical — attending a hospital department multiple times a week for three months is difficult around work, school and childcare, and that is why courses are abandoned. Home units exist in some systems. Ask about travel and appointment times before starting, not after.
Two skin conditions at once, treatments that help one and worsen the other, sequencing, and skin conditions alongside other illness or medication.
Can I develop a contact allergy on top of eczema? #
Yes, and it is common — people with eczema apply more products to more permeable skin for longer, which is how sensitisation happens.
Read the full answerHide the full answer
Contact allergy layered on atopic eczema is frequent and frequently missed, because it presents as the original condition getting worse rather than as something new. The clues are specific: eczema that stops responding to treatment that used to work, a change in distribution towards hands, eyelids or face, spread slightly beyond the areas being treated, and itching that is more prominent than stinging. The usual sensitisers are the ones you are most exposed to — preservatives in emollients, fragrance, lanolin, rubber accelerators in gloves, hair products, and occasionally the topical steroid itself. Occupational exposures are a major contributor in adults. What to do about it is straightforward: raise it explicitly and ask about patch testing, since this scenario is one of the clearest indications for it, and take a list of everything you apply plus the products themselves so they can be tested alongside the standard series. In the meantime, simplifying to the plainest possible ointment removes many candidate allergens at once.
It is associated with more than skin — asthma and allergy, sleep disturbance, depression and anxiety, and in severe disease some cardiovascular and infection risk.
Read the full answerHide the full answer
Atopic dermatitis is increasingly understood as a systemic inflammatory condition rather than a purely cutaneous one, and the associations are worth knowing without being alarmed by them. The strongest are the atopic ones — asthma, allergic rhinitis and food allergy — and the consequences of chronic itch, principally sleep disturbance and its downstream effects on mood, concentration and quality of life, with well-documented raised rates of depression and anxiety. Beyond that the picture is more mixed: severe disease has been associated in population studies with cardiovascular risk factors, some autoimmune conditions, and an increased risk of skin and occasionally systemic infection, though how much is caused by the eczema itself versus by shared inflammation, sleep loss and treatment is not settled. Two practical implications rather than reasons to worry. Mention eczema when other symptoms are being investigated, since the connection is not always front of mind. And treat the modifiable parts — sleep, itch, mental health, smoking and general cardiovascular risk — as part of the same picture.
I have eczema and a food allergy — how do they interact? #
They travel together but work differently. A food allergy causes immediate reactions; it rarely drives day-to-day eczema, and avoiding the food will not clear your skin.
Read the full answerHide the full answer
Confirmed IgE-mediated food allergy — hives, swelling, vomiting or breathing difficulty within minutes — needs strict avoidance and an emergency plan regardless of your skin, and that is not negotiable. What it usually does not do is control your baseline eczema. A minority of children, particularly those with severe early-onset eczema, do have food-triggered eczematous flares appearing hours to a day after ingestion, and identifying those is worthwhile through an allergy service. But the common expectation, that eliminating the allergen will clear the skin, is generally disappointed, and the eczema still needs treating on its own terms. Two further points. The barrier link runs the other way round: exposure through damaged skin promotes sensitisation, so treating eczema well is part of allergy prevention rather than the reverse. And avoid extending avoidance beyond what has been confirmed — prolonged avoidance of foods that were previously tolerated can itself precipitate allergy, and unnecessary restriction carries nutritional cost in children.
Can I have eczema and psoriasis at the same time? #
Yes, though it is uncommon — and the treatments diverge enough that getting the label right for each area genuinely changes what you apply.
Read the full answerHide the full answer
The two were long thought to be nearly mutually exclusive because they involve different immune pathways, but coexistence is documented and increasingly recognised, and some people have overlapping features that resist neat classification. Where both are present, treatment is regional rather than uniform: eczematous areas need emollient volume and anti-inflammatory treatment, while psoriatic plaques respond to vitamin D analogues and coal tar preparations that would be irritating and unhelpful on eczema. Two practical complications are worth knowing. Systemic treatment choices differ, since drugs targeting one pathway can occasionally unmask or worsen the other — paradoxical eczema on some psoriasis biologics is a recognised phenomenon. And distinguishing which patch is which is genuinely difficult in a mixed picture, so biopsy is used more often here than in either condition alone. If you have been treated for one for years without adequate control, and some areas behave differently from others, that observation is worth raising specifically rather than assuming a single diagnosis explains everything.
Yes — they share underlying immune biology and cluster in the same people and families, a sequence often called the atopic march.
Read the full answerHide the full answer
The three conditions share a type 2 inflammatory mechanism and a common genetic background, and they frequently appear in a characteristic order: eczema in infancy, food allergy, then asthma and allergic rhinitis in childhood. That sequence is the atopic march, and it is a pattern rather than an inevitability — plenty of people have one and never develop the others. The barrier hypothesis links them directly: allergen exposure through damaged skin appears to promote sensitisation in a way that oral exposure does not, which is part of why treating infant eczema well, and introducing allergenic foods early, are both taken seriously. Practically, the connection matters in three ways. Ask about the others if you have one, particularly a persistent cough or wheeze in a child with eczema. Treatments overlap: dupilumab treats both eczema and asthma, which can consolidate care. And flares often coincide — hay fever season worsens eczema in many people, and treating the rhinitis sometimes settles the skin.
How do I treat acne and eczema at the same time? #
Treat the eczema first and stabilise the barrier, then reintroduce acne actives slowly. Inflamed, permeable skin cannot tolerate a retinoid, and forcing it fails both.
Read the full answerHide the full answer
These conditions pull in opposite directions: acne treatment removes and dries, eczema treatment restores and occludes. Trying to run both at full intensity produces a barrier that fails, at which point the acne treatment becomes intolerable and gets abandoned. Sequence solves most of it. Settle the eczema first with emollients used generously and whatever topical anti-inflammatory has been prescribed, and give it a couple of weeks. Then reintroduce one acne active at low frequency, applied only to acne-prone areas rather than the eczema-prone ones — the two rarely occupy identical territory, and treating regionally is entirely legitimate. Choose the gentler options: azelaic acid over a strong retinoid, a non-foaming cleanser, benzoyl peroxide sparingly and not on eczematous skin. Moisturise before the active rather than after if stinging is the limiting factor. If both are moderate and neither can be controlled without upsetting the other, that is a genuine reason to be seen rather than a routine to be perfected at home.
Reading a label for this condition, what to ignore, expiry and storage, decanting for travel, a discontinued favourite, dupes, and what is genuinely worth paying for.
Are expensive eczema creams better than cheap ones? #
Almost never in proportion to price. Petrolatum costs very little and outperforms most premium creams; what price buys is texture, packaging and marketing.
Read the full answerHide the full answer
The most effective emollient ingredient in common use is petrolatum, which is among the cheapest substances in the category, and plain white soft paraffin sits at the top of the occlusive scale while costing a fraction of a branded cream. Trials comparing emollients against each other rarely produce a clear winner, and the variable that reliably predicts outcome is quantity used rather than price paid. That is the argument for buying cheaply and generously: eczema needs hundreds of grams a week, and an expensive cream almost guarantees under-application. Where money legitimately buys something: a texture you will actually apply four times a day, pump packaging that keeps a product hygienic and dispenses easily, and formulations combining ceramides and humectants that some people find noticeably better. Where it buys nothing: botanical extracts, marine ingredients, and anything sold on a story. The practical test before paying a premium is whether you would still use the same volume of a basic ointment. If yes, buy the basic ointment and use twice as much.
Does an eczema association seal on a product mean anything? #
A modest amount. It signals a review against irritancy criteria and a fee paid, not a clinical trial or proof that it works better than alternatives.
Read the full answerHide the full answer
Seals from patient organisations, most prominently the National Eczema Association's Seal of Acceptance, indicate that a product was submitted for review, that its ingredients were assessed against criteria intended to exclude common irritants and sensitisers, and that data on irritancy were provided. That is genuinely useful as a filter — it makes a fragranced or obviously sensitising product unlikely. What it is not: evidence of efficacy, a comparative ranking, or an indication that a product outperforms an unlabelled one. Manufacturers pay to participate, so absence of a seal says nothing at all, and many excellent plain emollients carry no seal because nobody applied for one. Treat it as one weak positive signal among several, below the ingredient list and well below whether you will use the product in adequate quantity. The same applies to dermatologist-tested, hypoallergenic and clinically proven, none of which have regulated definitions. If a claim cannot be checked against the ingredient list, it is marketing.
No — unscented products often contain a masking fragrance to hide a base smell, whereas fragrance-free means none was added, and that is the label worth trusting.
Read the full answerHide the full answer
The distinction is not pedantry and it catches people out constantly. Unscented describes the experience — the product does not smell of anything — and that effect is frequently achieved by adding a masking fragrance to neutralise the raw material odour. Fragrance-free indicates that no fragrance was added at all. Since fragrance is among the most common causes of allergic contact dermatitis and a routine irritant on compromised skin, the second is what you want. Reading the ingredient list is more reliable than either claim, since neither term is tightly regulated in most markets: look for parfum, fragrance, aroma, and the named fragrance allergens that European labelling requires, such as linalool and limonene, which frequently appear in products marketed as natural. Essential oils count as fragrance for this purpose regardless of how they are listed. Two extras: a product that smells pleasantly of anything almost certainly contains fragrance, and this applies to laundry products, hand washes and shower gels as much as to the moisturiser.
Test it on a small patch of forearm twice daily for five to seven days before putting it anywhere else, and change only one product at a time.
Read the full answerHide the full answer
A home use test is not a substitute for formal patch testing, but it catches a useful proportion of problems for the price of a week's patience. Apply the product to a small area of inner forearm, twice a day, for five to seven days, and watch for redness, itching, bumps or stinging that persists rather than passing in a minute. Reactions to a genuine sensitiser typically appear after a day or two rather than immediately, which is why a single application proves little. If it passes, introduce it to a small area of the face or the intended site for another few days before adopting it fully. Two rules make the whole exercise meaningful. Change one product at a time and hold everything else steady, because introducing three things at once makes attribution impossible. And test on skin that is currently calm, since a flare underway will make almost anything sting and produce a false verdict. If you have a history of reacting to several products, formal patch testing is the more efficient route.
How should I store emollient, and does hygiene matter? #
Use a pump or a clean spoon rather than fingers, keep it cool and closed, and note the open-jar date — and be aware paraffin-based products are flammable on fabric.
Read the full answerHide the full answer
Three things matter and one of them is a genuine safety issue. Contamination first: dipping hands into a communal tub repeatedly introduces bacteria into a product that will be applied to broken skin, so use a pump dispenser where available or decant with a clean spoon, and never share a tub across a household by hand. Second, storage and shelf life: keep products closed, cool and out of direct sun, note the period-after-opening symbol, and discard anything that changes colour, separates or smells different — an emollient does not become dangerous so much as unpleasant and potentially contaminated. Third, and most important, paraffin-based emollients are flammable. They soak into clothing, bedding and dressings, and fabric contaminated with them can ignite easily and burn fiercely near a naked flame, cigarette or heater — there have been fatalities. This applies to all paraffin-containing products regardless of concentration. Wash bedding and nightwear regularly at a high temperature, and keep all sources of ignition away from anyone using them.
Fragrance first, then essential oils, then known sensitising preservatives. Urea and lactic acid are useful on intact skin and sting badly on broken skin.
Read the full answerHide the full answer
Four categories cover most trouble. Fragrance and parfum are the clearest — a leading cause of contact allergy in cosmetics and worth avoiding in everything applied to eczematous skin, including products labelled naturally fragranced. Essential oils belong in the same category, tea tree and lavender included, despite their positioning as gentle. Preservatives are more nuanced: all products containing water need them, but methylisothiazolinone and methylchloroisothiazolinone caused a documented epidemic of contact allergy and are best avoided, while others are far less problematic. Lanolin is a classic sensitiser in people with long-standing eczema, though modern purified versions are much less so. Then the useful-but-stinging group — urea, lactic acid, propylene glycol, salicylic acid — which help thickened dry skin and are miserable on fissured skin, so timing rather than avoidance is the answer. What to look for instead is a short ingredient list built on petrolatum, paraffin, glycerin, ceramides or shea, ideally in an ointment with no preservative at all.
Products, answers, therapy guides, tools and articles in one search. Brand names,
slang and abbreviations all work — accutane finds isotretinoin, bacne finds truncal acne.